Publications

Selected Publications

Giannetti, M. P., Olivieri, F., Godwin, G., Weller, E., Nicoloro-SantaBarbara, J., Bonadonna, P., Zanotti, R., Zanoni, G., Hartmann, K. and Castells, M. (2023) “Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders”, Allergy, 78(1), pp. 301–304.

Kirsch M., Stehle G.T., Konantz M., Passweg J., Dirnhofer S., Meyer S.C. and Hartmann K. (2022) 'Presence of neoplastic mast cells in ascites in advanced systemic mastocytosis', The Journal of Allergy and Clinical Immunology. In Practice [Epub ahead of print].

Valent P., Hartmann K., Bonadonna P., Gülen T., Brockow K., Alvarez-Twose I., Hermine O., Niedoszytko M., Carter M. C., Hoermann G., Butterfield J. H., Lyons J. J., Sperr W. R., Greiner G., Sotlar K., Kluin-Nelemans H. C., Schwaab J., Lange M., George T. I., Siebenhaar F., Broesby-Olsen S., Jawhar M., Nedoszytko B., Castells M., Orfao A., Gotlib J., Reiter A., Horny H.-P., Triggiani M., Arock M., Metcalfe D. D. and Akin C. (2022) ‘Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium’, The Journal of Allergy and Clinical Immunology. In Practice 10(8), pp. 1941-1950

Peters, F., Fiebig, B., Lundberg, P., Jaspers, N.-I., Holzapfel, B., Ghadimi, M. P., Drebber, U., Tuchscherer, A., Ullrich, R., Hartmann, K. and Tantcheva-Poór, I. (2021) ‘Detection of the germline KIT S476I mutation in a kindred with familial mastocytosis associated with gastrointestinal stromal tumors’, The Journal of Allergy and Clinical Immunology. In Practice, 9(5), pp. 2123-2125

Steveling-Klein, E. H., Mateluna, C. M., Meienberg, A., Hartmann, K., Bircher, A. and Scherer Hofmeier, K. (2021) ‘Management of hypersensitivity reactions to nondextran iron products: new insights into predisposing risk factors’, The Journal of Allergy and Clinical Immunology. In Practice, 9(6), pp. 2406-2414

Hartmann, K., Gotlib, J., Akin, C., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Menssen, H. D. Redhu, S., Knoll, S., Sotlar, K., George, T. I., Horny, H.-P., Valent, P., Reiter, A. and Kluin-Nelemans, H. C. ‘Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis’, The Journal of Allergy and Clinical Immunity 2020, 146(2), pp. 356-366

Recke, A., Massalme, E. G., Jappe, U., Steinmüller-Magin, L., Schmidt, J., Hellenbroich, Y., Hüning, I., Gillessen-Kaesbach, G., Zillikens, D. and Hartmann, K. ‘Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema’, Clinical and Translational Allergy 2019, 9, p. 9

Gotlib, J., Kluin-Nelemans, H. C., George, T. I., Akin, C., Sotlar, K., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Sternberg, D. W., Villeneuve, M., Huntsman Labed, A., Stanek, E. J., Hartmann, K., Horny, H.-P., Valent, P. and Reiter, A. ‘Efficacy and safety of midostaurin in advanced systemic mastocytosis’, The New England Journal of Medicine 2016, 374(26), pp. 2530-2541

Hartmann, K., Escribano, L., Grattan, C., Brockow, K., Carter, M. C., Alvarez-Twose, I., Matito, A., Broesby-Olsen, S., Siebenhaar, F., Lange, M., Niedoszytko, M., Castells, M., Oude Elberink, J. N. G., Bonadonna, P., Zanotti, R., Hornick, J. L., Torrelo, A., Grabbe, J., Rabenhorst, A., Nedoszytko, B., Butterfield, J. H., Gotlib, J., Reiter, A., Radia, D., Hermine, O., Sotlar, K., George, T. I., Kristensen, T. K., Kluin-Nelemans, H. C., Yavuz, S., Hägglund, H., Sperr, W. R., Schwartz, L. B., Triggiani, M., Maurer, M., Nilsson, G., Horny, H.-P., Arock, M., Orfao, A., Metcalfe, D. D., Akin, C. and Valent, P. ‘Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology’, The Journal of Allergy and Clinical Immunology 2016, 137(1), pp. 35-45

Rabenhorst, A., Leja, S., Schwaab, J., Gehring, M., Förster, A., Arock, M., Reiter, A., Raap, U. and Hartmann, K. ‘Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity’, The Journal of Allergy and Clinical Immunology 2016, 137(1), pp. 314-318

Förster, A., Blissenbach, B., Machova, A., Leja, S., Rabenhorst, A., Wilmschen, S., Heger, K., Schmidt-Supprian, M., Roers, A., Hartmann, K. and Papadopoulou, N. ‘Dicer is indispensable for the development of murine mast cells’, The Journal of Allergy and Clinical Immunology 2015, 135(4), pp. 1077-1080

All Publications

2023

Konantz, M., Merkel, T., Meyer, S. C. and Hartmann, K. (2023) “MRGPRX2: A novel biomarker in mastocytosis?”, The Journal of Allergy and Clinical Immunology. In Practice, 11(2), pp. 669–671.

Akin, C., Brockow, K., Hartmann, K. and Nilsson, G. P. (2023) “Legends of Allergy and Immunology - Dean D. Metcalfe”, Allergy, p. [Epub ahead of print].

Valent, P., Hartmann, K., Bonadonna, P., Sperr, W. R., Niedoszytko, M., Hermine, O., Kluin-Nelemans, H. C., Sotlar, K., Hoermann, G., Nedoszytko, B., Broesby-Olsen, S., Zanotti, R., Lange, M., Doubek, M., Brockow, K., Alvarez-Twose, I., Varkonyi, J., Yavuz, S., Nilsson, G., Radia, D., Grattan, C., Schwaab, J., Gülen, T., Oude Elberink, H. N. G., Hägglund, H., Siebenhaar, F., Hadzijusufovic, E., Sabato, V., Mayer, J., Reiter, A., Orfao, A., Horny, H.-P., Triggiani, M. and Arock, M. (2023) “European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives”, The Journal of Allergy and Clinical Immunology. In Practice, p. [Epub ahead of print].

Lübke, J., Schwaab, J., Christen, D., Elberink, H. O., Span, B., Niedoszytko, M., Gorska, A., Lange, M., Gleixner, K. V., Hadzijusufovic, E., Solomianyi, O., Angelova-Fischer, I., Zanotti, R., Bonifacio, M., Bonadonna, P., Shoumariyeh, K., von Bubnoff, N., Müller, S., Perkins, C., Elena, C., Malcovati, L., Hagglund, H., Mattsson, M., Parente, R., Varkonyi, J., Fortina, A. B., Caroppo, F., Zink, A., Brockow, K., Breynaert, C., Bullens, D., Yavuz, A. S., Doubek, M., Sabato, V., Schug, T., Niederwieser, D., Hartmann, K., Triggiani, M., Gotlib, J., Hermine, O., Arock, M., Kluin-Nelemans, H. C., Panse, J., Sperr, W. R., Valent, P., Reiter, A. and Jawhar, M. (2023) “Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis”, The Journal of Allergy and Clinical Immunology. In Practice, 11(2), pp. 581–590.e5.

Bellutti-Enders, F., Elkuch, M., Wörner, A., Scherer-Hofmeier, K. and Hartmann, K. (2023) “Alpha-gal syndrome initially misdiagnosed as chronic spontaneous urticaria in a pediatric patient: a case report and review of the literature”, Journal of Medical Case Reports, 17(1), p. 6.

2022

Jennings, S. V., Finnerty, C. C., Hobart, J. S., Martín-Martínez, M., Sinclair, K. A., Slee, V. M., Agopian, J., Akin, C., Álvarez-Twose, I., Bonadonna, P., Bowman, A. S., Brockow, K., Bumbea, H., de Haro, C., Fok, J. S., Hartmann, K., Hegmann, N., Hermine, O., Kalisiak, M., Katelaris, C. H., Kurz, J., Marcis, P., Mayne, D., Mendoza, D., Moussy, A., Mudretzkyj, G., Vaia, N. N., Niedoszytko, M., Elberink, H. O., Orfao, A., Radia, D. H., Rosenmeier, S., Ribada, E., Schinhofen, W., Schwaab, J., Siebenhaar, F., Triggiani, M., Tripodo, G., Velazquez, R., Wielink, Y., Wimazal, F., Yigit, T., Zubrinich, C. and Valent, P. (2022) “Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond”, The Journal of Allergy and Clinical Immunology. In Practice, 10(8), pp. 2039–2051.

Kennedy V. E., Perkins C., Reiter A., Jawhar M., Lübke J., Kluin-Nelemans H. C., Shomali W., Langford C., Abuel J., Hermine O., Niedoszytko M., Gorska A., Mital A., Bonadonna P., Zanotti R., Tanasi I., Mattsson M., Hagglund H. G., Triggiani M., Yavuz A. S., Panse J. P., Christen D., Heizmann M., Shoumariyeh K., Müller S., Elena C., Malcovati L., Fiorelli N., Wortmann F., Vucinic V., Brockow K., Fokoloros C., Papageorgiou S. G., Breynaert C., Bullens D., Doubek M., Ilerhaus A., Angelova-Fischer I., Solomianyi O., Varkonyi J., Sabato V., Rüfer A., Schug T., Hermans M. A. W., Belloni Fortina A., Caroppo F., Bumbea H., Gulen T., Hartmann K., Oude Elberink H., Schwaab J., Arock M., Valent P., Sperr W., Gotlib J. (2022) ‘Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry’, Blood Advances 2022, [Epub ahead of print]

Kirsch M., Stehle G.T., Konantz M., Passweg J., Dirnhofer S., Meyer S.C. and Hartmann K. (2022) 'Presence of neoplastic mast cells in ascites in advanced systemic mastocytosis', J Allergy Clin Immunol Pract, [Epub ahead of print].

Roth M. S., Chantraine S., Morales Mateluna C., Hartmann K. and Berger C. T. (2022) ‘Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose’, J Eur Acad Dermatol Venereol, [Epub ahead of print]

Pyatilova P., Akin C., Alvarez-Twose I., Arock M., Bonadonna P., Brockow K., Butterfield J. H., Broesby-Olsen S., Carter M. C., Castells M., George T. I., Gotlib J., Greiner G., Gülen T., Hartmann K., Hermine O., Horny H.-P., Jawhar M., Lange M., Lyons J. J., Maurer M., Metcalfe D. D., Nedoszytko B., Niedoszytko M., Orfao A., Reiter A., Schwaab J., Sotlar K., Sperr W. R., Triggiani M., Valent P. and Siebenhaar F. (2022) ‘Refined treatment response criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium’, J Allergy Clin Immunol Pract, 10(8), pp. 2015-2024

Sotlar K., George T. I., Kluin P., Reiter A., Schwaab J., Panse J., Brockow K., Hartmann K., Sperr W. R., Kristensen T., Nedoszytko B., Carter M., Bonadonna P., Lyons J. J., Kluin-Nelemans H. C., Hermine O., Akin C., Broesby-Olsen S., Hoermann G., Triggiani M., Butterfield J. H., Jawhar M., Gotlib J., Metcalfe D. D., Orfao A., Arock M., Valent P. and Horny H.-P. (2022) ‘Standards of pathology in the diagnosis of systemic mastocytosis: recommendations of the EU-US cooperative group’, J Allergy Clin Immunol Pract, 10(8), pp. 1986-1998

Gotlib J., Schwaab J., Shomali W., George T. I., Radia D. H., Castells M., Carter M. C., Hartmann K., Alvarez-Twose I., Brockow K., Bonadonna P., Hermine O., Niedoszytko M., Hoermann G., Sperr W. R., Elberink H. O., Siebenhaar F., Butterfield J. H., Ustun C., Zanotti R., Triggiani M., Schwartz L. B., Lyons J. J., Orfao A., Sotlar K., Horny H.-P., Arock M., Metcalfe D. D., Akin C., Lübke J., Valent P. and Reiter A. (2022) ‘Proposed ECNM-AIM response criteria in advanced systemic mastocytosis’, J Allergy Clin Immunol Pract, 10(8), pp. 2025-2038

Valent P., Hartmann K., Bonadonna P., Gülen T., Brockow K., Alvarez-Twose I., Hermine O., Niedoszytko M., Carter M. C., Hoermann G., Butterfield J. H., Lyons J. J., Sperr W. R., Greiner G., Sotlar K., Kluin-Nelemans H. C., Schwaab J., Lange M., George T. I., Siebenhaar F., Broesby-Olsen S., Jawhar M., Nedoszytko B., Castells M., Orfao A., Gotlib J., Reiter A., Horny H.-P., Triggiani M., Arock M., Metcalfe D. D. and Akin C. (2022) ‘Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium’, J Allergy Clin Immunol Pract, 10(8), pp. 1941-1950

Arock M., Hoermann G., Sotlar K., Hermine O., Sperr W. R., Hartmann K., Brockow K., Akin C., Triggiani M., Broesby-Olsen S., Reiter A., Gotlib J., Horny H.-P., Orfao A., Metcalfe D. D. and Valent P.(2022) ‘Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: status 2022’, J Allergy Clin Immunol, 149(6), pp. 1855-1865

Valent P., Akin C., Hartmann K., Reiter A., Gotlib J., Sotlar K., Sperr W. R., Degenfeld-Schonburg L., Smiljkovic D., Triggiani M., Horny H.-P., Arock M., Galli S. J. and Metcalfe D. D. (2022) ‘Drug-induced mast cell eradication: a novel approach to treat mast cell activation disorders?’, J Allergy Clin Immunol, 149(6), pp. 1866-1874

Valent P., Hartmann K., Bonadonna P., Niedoszytko M., Triggiani M., Arock M. and Brockow K. (2022) ‘Mast cell activation syndromes: collegium internationale allergologicum update 2022’, Int Arch Allergy Immunol, 183(7), pp. 693-705

Nsiah‐Dosu S., Scholz C., Orinska Z., Sadik C. D., Ludwig R. J., Schmidt E., Zillikens D. and Hartmann K. (2021) ‘Mast cell‐deficient mice Mcpt5Cre/Dicerfl/fl redefine the role of mast cells in experimental bullous pemphigoid’, Skin Health and Disease, 2(1), p. e70

Redhu D., Franke K., Aparicio-Soto M., Kumari V., Pazur K., Illerhaus A., Hartmann K., Worm M. and Babina M. (2022) ‘Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: relevance of the tryptase/protease-activated receptor 2 axis’, J Allergy Clin Immunol, 149(6), pp. 2053-2061

Hoermann G., Sotlar K., Jawhar M., Kristensen T., Bachelot G., Nedoszytko B., Carter MC., Horny H.-P., Bonadonna P., Sperr W. R., Hartmann K., Brockow K., Lyons J. J., Kluin-Nelemans H. C., Hermine O., Akin C., Broesby-Olsen S., Triggiani M., Butterfield J. H., Schwaab J., Reiter A., Gotlib J., Metcalfe D. D., George T. I., Orfao A., Valent P. and Arock M. (2022) ‘Standards of genetic testing in the diagnosis and prognostication of systemic mastocytosis in 2022: recommendations of the EU-US cooperative group’, J Allergy Clin Immunol Pract, 10(8), pp. 1953-1963

Valent P., Hartmann K., Schwaab J., Alvarez-Twose I., Brockow K., Bonadonna P., Hermine O., Niedoszytko M., Carter M. C., Hoermann G., Sperr W. R., Butterfield J. H., Ustun C., Zanotti R., Radia D. H., Castells M., Triggiani M., Schwartz L. B., Orfao A., George T. I., Sotlar K., Gotlib J., Reiter A., Horny H.-P., Arock M., Akin C. and Metcalfe D. D. (2022) ‘Personalized management strategies in mast cell disorders: ECNM-AIM user's guide for daily clinical practice’, J Allergy Clin Immunol Pract, 10(8), pp. 1999-2012

Bergmann C., Poli A., Agache I., Bianchini R., Bax H. J., Castells M., Crescioli S., Dombrowicz D., Ferastraoaru D., Fiebiger E., Gould H. J., Hartmann K., Izquierdo E., Jordakieva G., Josephs D. H., Jutel M., Levi-Schaffer F., de Las Vecillas L., Lotze M. T., Osborn G., Pascal M., Redegeld F., Rosenstreich D., Roth-Walter F., Schmidt-Weber C. B., Shamji M., Steveling E. H., Turner M. C., Untersmayr E., Jensen-Jarolim E. and Karagiannis S. N. (2022) ‘AllergoOncology: danger signals in allergology and oncology. A European Academy of Allergy and Clinical Immunology (EAACI) position paper’, Allergy. p. [Epub ahead of print]

Valent P., Akin C., Hartmann K., Alvarez-Twose I., Brockow K., Hermine O., Niedoszytko M., Schwaab J., Lyons J. J., Carter M. C., Elberink H. O., Butterfield J. H., George T. I., Greiner G., Ustun C., Bonadonna P., Sotlar K., Nilsson G., Jawhar M., Siebenhaar F., Broesby-Olsen S., Yavuz S., Zanotti R., Lange M., Nedoszytko B., Hoermann G., Castells M., Radia D. H., Muñoz-Gonzalez J. I., Sperr W. R., Triggiani M., Kluin-Nelemans H. C., Galli S. J., Schwartz L. B., Reiter A., Orfao A., Gotlib J., Arock M., Horny H.-P. and Metcalfe D. D. (2021) ‘Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal’, Hemasphere, 13(11), p. e646

2021

Bürgler, A., Glick, S., Hartmann, K. and Eeftens, M. (2021) ‘Rationale and design of a panel study investigating six health effects of airborne pollen: the EPOCHAL study’, Frontiers in Public Health, 9, p. 689248

Gulen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., Sperr, W. R., Alvarez-Twose, I., Horny, H.-P., Sotlar, K., Schwaab, J., Jawhar, M., Zanotti, R., Nilsson, G., Lyons, J. J., Carter, M. C., George, T. I., Hermine, O., Gotlib, J., Orfao, A., Triggiani, M., Reiter, A., Hartmann, K., Castells, M., Arock, M., Schwartz, L. B., Metcalfe, D. D. and Valent, P. (2021) ‘Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review’, The Journal of Allergy and Clinical Immunology. In Practice, 9(11), pp. 3918-3928

Hirsiger, J. R., Heijnen, I. A. F. M., Hartmann, K. and Berger, C. T. (2021) ‘Anaphylaxis to goat’s and sheep’s milk in an adult tolerant to cow milk: a sensitization profile study’, Journal of Investigational Allergology & Clinical Immunology, 32(2), pp.154-156

Klimek, L., Bergmann, K.-C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., Jakob, T., Novak, N., Ring, J., Merk, H., Hamelmann, E., Ankermann, T., Schmidt, S., Untersmayr, E., Hötzenecker, W., Jensen-Jarolim, E., Brockow, K., Mahler, V. and Worm, M. (2021) ‘Practical handling of allergic reactions to COVID-19 vaccines: a position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI’, Allergo Journal International, 30(3), pp. 79-95

Bonadonna, P., Brockow, K., Niedoszytko, M., Elberink, H. O., Akin, C., Nedoszytko, B., Butterfield, J. H., Alvarez-Twose, I., Sotlar, K., Schwaab, J., Jawhar, M., Castells, M., Sperr, W. R., Hermine, O., Gotlib, J., Zanotti, R., Reiter, A., Broesby-Olsen, S., Bindslev-Jensen, C., Schwartz, L. B., Horny, H.-P., Radia, D., Triggiani, M., Sabato, V., Carter, M. C., Siebenhaar, F., Orfao, A., Grattan, C., Metcalfe, D. D., Arock, M., Gulen, T., Hartmann, K. and Valent, P. (2021) ‘COVID-19 vaccination in mastocytosis: recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)’, The Journal of Allergy and Clinical Immunology. In Practice, 9(6), pp. 2139-2144

Lange, M., Hartmann, K., Carter, M. C., Siebenhaar, F., Alvarez-Twose, I., Torrado, I., Brockow, K., Renke, J., Irga-Jaworska, N., Plata-Nazar, K., Lugowska-Umer, H., Czarny, J., Belloni Fortina, A., Caroppo, F., Nowicki, R. J., Nedoszytko, B., Niedoszytko, M. and Valent, P. (2021) ‘Molecular background, clinical features and management of pediatric mastocytosis: status 2021’, International journal of molecular sciences, 22(5), p. 2586

Aberer, E., Sperr, W. R., Bretterklieber, A., Avian, A., Hadzijusufovic, E., Kluin-Nelemans, H. C., Elberink, H. O., van Anrooij, B., Niedoszytko, M., Lange, M., Górska, A., Elena, C., Brazzelli, V., Fortina, A. B., Caroppo, F., Hartmann, K., Illerhaus, A., Reiter, A., Jawhar, M., Bonadonna, P., Zanotti, R., Triggiani, M., Parente, R., Gotlib, J., Doubek, M., von Bubnoff, N., Fuchs, D., Sabato, V., Brockow, K., Jäkel, N., Panse, J. and Valent, P. (2021) ‘Clinical impact of skin lesions in mastocytosis: a multicenter study of the European Competence Network on Mastocytosis (ECNM)’, The Journal of Investigative Dermatology, 141(7), pp. 1719-1727

Giannetti, M. P., Weller, E., Alvarez-Twose, I., Torrado, I., Bonadonna, P., Zanotti, R., Dwyer, D. F., Foer, D., Akin, C., Hartmann, K., Rama, T. A., Sperr, W. R., Valent, P., Teodosio, C., Orfao, A. and Castells, M. (2021) ‘COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms’, The Journal of Allergy and Clinical Immunology. In Practice, 9(5), pp. 2083-2086

Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., Bauer, A., Merk, H., Rabe, U., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Mülleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Jakob, T., Ankermann, T., Schmidt, S. M., Gerstlauer, M., Vogelberg, C., Zuberbier, T., Hartmann, K. and Worm, M. (2021) ‘Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)’, Allergo Journal International, 30(2), pp. 51–55

Peters, F., Fiebig, B., Lundberg, P., Jaspers, N.-I., Holzapfel, B., Ghadimi, M. P., Drebber, U., Tuchscherer, A., Ullrich, R., Hartmann, K. and Tantcheva-Poór, I. (2021) ‘Detection of the germline KIT S476I mutation in a kindred with familial mastocytosis associated with gastrointestinal stromal tumors’, The Journal of Allergy and Clinical Immunology. In Practice, 9(5), pp. 2123-2125

Kluin-Nelemans, H. C., Jawhar, M., Reiter, A., van Anrooij, B., Gotlib, J., Hartmann, K., Illerhaus, A., Oude Elberink, H. N. G., Gorska, A., Niedoszytko, M., Lange, M., Scaffidi, L., Zanotti, R., Bonadonna, P., Perkins, C., Elena, C., Malcovati, L., Shoumariyeh, K., von Bubnoff, N., Müller, S., Triggiani, M., Parente, R., Schwaab, J., Kundi, M., Fortina, A. B., Caroppo, F., Brockow, K., Zink, A., Fuchs, D., Angelova-Fischer, I., Yavuz, A. S., Doubek, M., Mattsson, M., Hagglund, H., Panse, J., Simonowski, A., Sabato, V., Schug, T., Jentzsch, M., Breynaert, C., Várkonyi, J., Kennedy, V., Hermine, O., Rossignol, J., Arock, M., Valent, P. and Sperr, W. R. (2021) ‘Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis’, Theranostics, 11(1), pp. 292-303

Gotlib, J., Kluin-Nelemans, H. C., Akin, C., Hartmann, K., Valent, P. and Reiter, A. (2020) ‘Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin’, Expert Opinion on Biological Therapy, 21(4), pp. 487-498

Fuchs, D., Kilbertus, A., Kofler, K., von Bubnoff, N., Shoumariyeh, K., Zanotti, R., Bonadonna, P., Scaffidi, L., Doubek, M., Elberink, H. O., Span, L. F. R., Hermine, O., Elena, C., Benvenuti, P., Yavuz, A. S., Brockow, K., Zink, A., Aberer, E., Gorska, A., Romantowski, J., Hadzijusufovic, E., Fortina, A. B., Caroppo, F., Perkins, C., Illerhaus, A., Panse, J., Vucinic, V., Jawhar, M., Sabato, V., Triggiani, M., Parente, R., Bergström, A., Breynaert, C., Gotlib, J., Reiter, A., Hartmann, K., Niedoszytko, M., Arock, M., Kluin-Nelemans, H. C., Sperr, W. R., Greul, R. and Valent, P. (2020) ‘Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin’, The Journal of Allergy and Clinical Immunology. In Practice, 9(4), pp. 1705-1712

Trachsel, T., Manjaly Thomas, Z.-R., Chantraine, S., Link, S., Heijnen, I., Scherer Hofmeier, K. and Hartmann, K. (2021) ‘Cannabisallergie’, Swiss Medical Forum, 21(25-26), pp. 449–451

Steveling-Klein, E. H., Mateluna, C. M., Meienberg, A., Hartmann, K., Bircher, A. and Scherer Hofmeier, K. (2021) ‘Management of hypersensitivity reactions to nondextran iron products: new insights into predisposing risk factors’, The Journal of Allergy and Clinical Immunology. In Practice, 9(6), pp. 2406-2414

Jamiolkowski, D., Steveling-Klein, E., Manjaly Thomas, Z.-R., Bircher, A., Hofmeier, K. S. and Hartmann, K. (2021) ‘Structured diagnostic assessment of hand eczema in cleaning workers’, Journal der Deutschen Dermatologischen Gesellschaft, 19(5), pp. 672-676

Thomas, Z. M., Jamiolkowski, D., Chantraine, S., Steveling-Klein, E., Hofmeier, K. S. and Hartmann, K. (2021) 'Contact dermatitis to hair cosmetics: current diagnostic recommendations', Journal der Deutschen Dermatologischen Gesellschaft, 19(12), pp. 1729-1734

Zanotti, R., Bonifacio, M., Lucchini, G., Sperr, W. R., Scaffidi, L., van Anrooij, B., Oude Elberink, H. N., Rossignol, J., Hermine, O., Gorska, A., Lange, M., Hadzijusufovic, E., Miething, C., Müller, S., Perkins, C., Shomali, W., Elena, C., Illerhaus, A., Jawhar, M., Parente, R., Caroppo, F., Solomianyi, O., Zink, A., Mattsson, M., Yavuz, A. S., Panse, J., Varkonyi, J., Doubek, M., Sabato, V., Breynaert, C., Vucinic, V., Schug, T., Hägglund, H., Wortmann, F., Brockow, K., Angelova-Fischer, I., Belloni Fortina, A., Triggiani, M., Reiter, A., Hartmann, K., Malcovati, L., Gotlib, J., Shoumariyeh, K., Niedoszytko, M., Arock, M., Kluin-Nelemans, H. C., Bonadonna, P. and Valent, P. (2021) 'Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis', Leukemia, 36(2), pp. 516-524

Maris, I., Dölle-Bierke, S., Renaudin, J. M., Lange, L., Koehli, A., Spindler, T., Hourihane, J., Scherer, K., Nemat, K., Kemen, C., Neustädter, I., Vogelberg, C., Reese, T., Yildiz, I., Szepfalusi, Z., Ott, H., Straube, H., Papadopoulos, N. G., Hämmerling, S., Staden, U., Polz, M., Mustakov, T., Cichocka-Jarosz, E., Cocco, R., Fiocchi, A. G., Fernandez-Rivas, M. and Worm, M. (2021) ‘Peanut-induced anaphylaxis in children and adolescents: data from the European Anaphylaxis Registry’, Allergy, 6(5), pp. 1517-1527

Torres, M. J., Trautmann, A., Böhm, I., Scherer, K., Barbaud, A., Bavbek, S., Bonadonna, P., Cernadas, J., Chiriac, A., Gaeta, F., Gimenez-Arnau, A. M., Kang, H., Moreno, E. and Brockow, K. (2021) ‘Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity’, Allergy, 76(5), pp. 1325-1339

Dannenmann B., Klimiankou M., Oswald B., Solovyeva A., Mardan J., Nasri M., Ritter M., Zahabi A., Arreba-Tutusaus P., Mir P., Stein F., Kandabarau S., Lachmann N., Moritz T., Morishima T., Konantz M., Lengerke C., Ripperger T., Steinemann D., Erlacher M., Niemeyer C. M., Zeidler C., Welte K. and Skokowa J. (2021) ‘iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia’, Cell Stem Cell, 28(5), pp. 906-922.e6

Schmitt A., Xu W., Bucher P., Grimm M., Konantz M., Horn H., Zapukhlyak M., Berning P., Brändle M., Jarboui M. A., Schönfeld C., Boldt K., Rosenwald A., Ott G., Grau M., Klener P., Vockova P., Lengerke C., Lenz G., Schulze-Osthoff K. and Hailfinger S. (2021) ‘Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL’, Blood, 138(19), pp. 871-884

Landerer H., Arnone M., Wieboldt R., Goersch E., Stanger A. M. P., Konantz M. and Lengerke C. (2021) ‘Two flow cytometric approaches of NKG2D ligand surface detection to distinguish stem cells from bulk subpopulations in acute myeloid leukemia’, Journal of Visualized Experiments, 168, p. [Epub ahead of print]

Sonay A. Y., Kalyviotis K., Yaganoglu S., Unsal A., Konantz M., Teulon C., Lieberwirth I., Sieber S., Jiang S., Behzadi S., Crespy D., Landfester K., Roke S., Lengerke C. and Pantazis P. (2021) ‘Biodegradable harmonophores for targeted high-resolution in vivo tumor imaging’, ACS Nano, 15(3), pp. 4144-4154

Atallah I., Quinodoz M., Campos-Xavier B., Peter V. G., Fouriki A., Bonvin C., Bottani A., Kumps C., Angelini F., Bellutti Enders F., Christen-Zaech S., Rizzi M., Renella R., Beck-Popovic M., Poloni C., Frossard V., Blouin J. L., Rivolta C., Riccio O., Candotti F., Hofer M., Unger S. and Superti-Furga A. (2021) ‘Immune deficiency, autoimmune disease and intellectual disability: a pleiotropic disorder caused by biallelic variants in the TPP2 gene’, Clinical Genetics, 99(6), pp. 780-788

Erni B., Navarini A. A., Huang D., Schoetzau A., Kind A. and Mueller S. M. (2021) ‘Proposition of a severity scale for lichen sclerosus: the "Clinical Lichen Sclerosus Score"’, Dermatologic Therapy, 34(2), p. e14773

2020

Worm, M., Ballmer-Weber, B., Brehler, R., Cuevas, M., Gschwend, A., Hartmann, K., Hawranek, T., Hötzenecker, W., Homey, B., Jakob, T., Novak, N., Pickert, J., Saloga, J., Schäkel, K., Trautmann, A., Treudler, R., Wedi, B., Sturm, G. and Rueff, F. (2020) ‘Healthcare provision for insect venom allergy patients during the COVID-19 pandemic’, Allergo Journal International, 29(8), pp. 257-261

Valent, P., Akin, C., Nedoszytko, B., Bonadonna, P., Hartmann, K., Niedoszytko, M., Brockow, K., Siebenhaar, F., Triggiani, M., Arock, M., Romantowski, J., Górska, A., Schwartz, L. B. and Metcalfe, D. D. (2020) ‘Diagnosis, classification and management of Mast Cell Activation Syndromes (MCAS) in the era of personalized medicine’, International Journal of Molecular Sciences, 21(23), p. 9030

Valent, P., Akin, C., Hartmann, K., Nilsson, G., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T. I., Kluin-Nelemans, H. C., Ustun, C., Triggiani, M., Brockow, K., Gotlib, J., Orfao, A., Kovanen, P. T., Hadzijusufovic, E., Sadovnik, I., Horny, H.-P., Arock, M., Schwartz, L. B., Austen, K. F., Metcalfe, D. D. and Galli, S. J. (2020) ‘Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich’s visions to precision medicine concepts’, Theranostics, 10(23), pp. 10743-10768

Ferastraoaru, D., Bax, H. J., Bergmann, C., Capron, M., Castells, M., Dombrowicz, D., Fiebiger, E., Gould, H. J., Hartmann, K., Jappe, U., Jordakieva, G., Josephs, D. H., Levi-Schaffer, F., Mahler, V., Poli, A., Rosenstreich, D., Roth-Walter, F., Shamji, M., Steveling-Klein, E. H., Turner, M. C., Untersmayr, E., Karagiannis, S. N. and Jensen-Jarolim, E. (2020) ‘AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer - a position paper of the European Academy of Allergy and Clinical Immunology (EAACI)’, Clinical and Translational Allergy, 10, article nr. 32

Ernst, N., Friedrich, M., Bieber, K., Kasperkiewicz, M., Gross, N., Sadik, C. D., Zillikens, D., Schmidt, E., Ludwig, R. J. and Hartmann, K. (2020) ‘Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris’, Journal of the European Academy of Dermatology and Venereology, 35(2), pp. 486-492

Valent, P., Akin, C., Bonadonna, P., Brockow, K., Niedoszytko, M., Nedoszytko, B., Butterfield, J. H., Alvarez-Twose, I., Sotlar, K., Schwaab, J., Jawhar, M., Reiter, A., Castells, M., Sperr, W. R., Kluin-Nelemans, H. C., Hermine, O., Gotlib, J., Zanotti, R., Broesby-Olsen, S., Horny, H.-P., Triggiani, M., Siebenhaar, F., Orfao, A., Metcalfe, D. D., Arock, M. and Hartmann, K. (2020) ‘Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: expert opinions’, The Journal of Allergy and Clinical Immunology, 146(2), pp. 300-306

Goldust, M., Hartmann, K., Abdelmaksoud, A. and Navarini, A. A. (2020) ‘Utility and risk of dermatologic medications during the COVID-19 pandemic’, Dermatologic Therapy, 33(6), p. e13833

Hartmann, K., Gotlib, J., Akin, C., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Menssen, H. D. Redhu, S., Knoll, S., Sotlar, K., George, T. I., Horny, H.-P., Valent, P., Reiter, A. and Kluin-Nelemans, H. C. (2020) ‘Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis’, The Journal of Allergy and Clinical Immunity, 146(2), pp. 356-366

Rongisch, R., Schmidt, E., Deresz, N., Schöfer, H., Schäkel, K., Jakob, T., Maurer, M., Sticherling, M., Sunderkötter, C., Babilas, P., Spornraft-Ragaller, P., Traidl-Hoffmann, C., Gläser, R., Hartmann, K., Kolb-Mäurer, A., Wenzel, J., Biedermann, T., Homey, B., Pfützner, W., Weid, F., Fischer, M., Linder, R. and von Stebut, E. (2020) ‘Travel-associated infectious skin diseases’, Journal der Deutschen Dermatologischen Gesellschaft, 18(7), pp. 730-733

Neumann, K., Niemer, M., Wildt, C., Anemüller, W., Zillikens, D. and Hartmann, K. (2020) ‘Natatorial mishap: skin lesions caused by jellyfish stings’, Journal der Deutschen Dermatologischen Gesellschaft, 18(5), pp. 473-475

Maurer, M., Eyerich, K., Eyerich, S., Ferrer, M., Gutermuth, J., Hartmann, K., Jakob, T., Kapp, A., Kolkhir, P., Larenas-Linnemann, D., Park, H.-S., Pejler, G., Sanchez-Borges, M., Schäkel, K., Simon, D., Simon, H.-U., Weller, K., Zuberbier, T. and Metz, M. (2020) ‘Urticaria: Collegium Internationale Allergologicum (CIA) update 2020’, International Archives of Allergy and Immunology, 181, pp. 321-333

Landolina, N., Zaffran, I., Smiljkovic, D., Serrano-Candelas, E., Schmiedel, D., Friedman, S., Arock, M., Hartmann, K., Pikarsky, E., Mandelboim, O., Martin, M., Valent, P. and Levi-Schaffer, F. (2020) ‘Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells’, Pharmacological Research, p. 104682

Trizuljak, J., Sperr, W. R., Nekvindová, L., Oude Elberink, H., Gleixner, K. V., Gorska, A., Lange, M., Hartmann, K., Illerhaus, A., Bonifacio, M., Perkins, C., Elena, C., Malcovati, L., Belloni Fortina, A., Shoumariyeh, K., Jawhar, M., Zanotti, R., Bonadonna, P., Caroppo, F., Zink, A., Triggiani, M., Parente, R., von Bubnoff, N., Selim Yavuz, A., Hägglund, H., Mattsson, M., Panse, J., Jäkel, N., Kilbertus, A., Hermine, O., Arock, M., Fuchs, D., Sabato, V., Brockow, K., Bretterklieber, A., Niedoszytko, M., van Anrooij, B., Reiter, A., Gotlib, J., Kluin-Nelemans, H. C., Mayer, J., Doubek, M. and Valent, P. (2020) ‘Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification’, Allergy, 75(8), pp. 1923-1934

Arock, M., Sotlar, K., Gotlib, J., Sperr, W. R., Hartmann, K., Schwartz, L. B., Akin, C., Horny, H.-P. and Valent, P. (2020) ‘New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the annual meeting of the European Competence Network on Mastocytosis (ECNM) 2019’, Leukemia & Lymphoma, 61(5), pp. 1075-1083

Kluin-Nelemans, H. C., Reiter, A., Illerhaus, A., van Anrooij, B., Hartmann, K., Span, L. F. R., Gorska, A., Niedoszytko, M., Lange, M., Scaffidi, L., Zanotti, R., Bonadonna, P., Perkins, C., Elena, C., Malcovati, L., Shoumariyeh, K., von Bubnoff, N., Parente, R., Triggiani, M., Schwaab, J., Jawhar, M., Caroppo, F., Fortina, A. B., Brockow, K., Zink, A., Fuchs, D., Kilbertus, A., Yavuz, A. S., Doubek, M., Mattsson, M., Hagglund, H., Panse, J., Sabato, V., Aberer, E., Niederwieser, D., Breynaert, C., Várkonyi, J., Kennedy, V., Lortholary, O., Jakob, T., Hermine, O., Rossignol, J., Arock, M., Gotlib, J., Valent, P. and Sperr, W. R. (2020) ‘Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry’, Leukemia, 34(4), pp. 1090-1101

Valent, P., Arock, M., Hadzijusufovic, E., Sperr, W. R., Hartmann, K., Akin, C., Metcalfe, D. D. and Horny, H.-P. (2020) ‘History and current status of mastocytosis research in the European Competence Network on Mastocytosis’, in Akin, C. (ed.) Mastocytosis. Cham: Springer, pp. 287-299

Manjaly Thomas, Z.-R. and Hartmann, K. (2019) ‘Skin disease in mastocytosis’, in Akin, C. (ed.) Mastocytosis. A Comprehensive Guide. Cham: Springer, pp. 69-91

Manjaly Thomas, Z.-R., Leuppi-Taegtmeyer, A., Jamiolkowski, D., Steveling-Klein, E., Bellutti-Enders, F., Hofmeier, K. S. and Hartmann, K. (2020) ‘Emerging treatments in COVID-19: adverse drug reactions including drug hypersensitivities’, The Journal of Allergy and Clinical Immunology, 146(4), pp. 786-789

Jamiolkowski, D., Steveling-Klein, E., Scherer Hofmeier, K. and Hartmann, K. (2020) ‘Multilocular bullous fixed drug eruption elicited by paracetamol and migraine attacks, but not by paracetamol alone’, Contact Dermatitis, 83(3), pp. 233-234

Kraft, M., Scherer Hofmeier, K., Ruëff, F., Pföhler, C., Renaudin, J. M., Bilò, M. B., Treudler, R., Lang, R., Cichocka-Jarosz, E., Fernandez-Rivas, M., Christoff, G., Papadopoulos, N. G., Ensina, L.F., Hourihane, J. O., Maris, I., Koehli, A., García, B. E., Jappe, U., Vogelberg, C., Ott, H., Lange, L., Spindler, T., Dölle-Bierke, S. and Worm, M. (2020) ‘Risk factors and characteristics of biphasic anaphylaxis’, The Journal of Allergy and Clinical Immunology: In Practice, 8(10), pp. 388-3395

Francuzik, W., Ruëff, F., Bauer, A., Bilò, M. B., Cardona, V., Christoff, G., Dölle-Bierke, S., Ensina, L., Fernández, Rivas M., Hawranek, T., Hourihane, J. O., Jakob, T., Papadopoulos, N.G., Pföhler, C., Poziomkowska-Gęsicka, I., Van der Brempt, X., Scherer Hofmeier, K., Treudler, R., Wagner, N., Wedi, B. and Worm, M. (2020) ‘Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry’, The Journal of Allergy and Clinical Immunology, 147(2),pp. 653-662

Terrani, I., Scherer Hofmeier, K. and Bircher, A. J. (2020) ‘Indium and iridium: two rare metals with a high rate of contact sensitization’, Contact Dermatitis, 83(3), pp. 233-234

Kraft, M., Knop, M. P., Renaudin, J. M., Scherer Hofmeier, K., Pföhler, C., Bilò, M. B., Lang, R., Treudler, R., Wagner, N., Spindler, T., Hourihane, J. O., Maris, I., Koehli, A., Bauer, A., Lange, L., Müller, S., Papadopoulos, N. G., Wedi, B., Moeser, A., Ensina, L. F., Fernandez-Rivas, M., Cichocka-Jarosz, E., Christoff, G., Garcia, B. E., Poziomkowska-Gęsicka, I., Cardona, V., Mustakov, T. B., Rabe, U., Mahler, V., Grabenhenrich, L., Dölle-Bierke, S. and Worm, M. (2020) ‘Secondary prevention measures in anaphylaxis patients: data from the anaphylaxis registry’, Allergy, 75(4), pp. 901-910

Mueller, S. M., Hongler, V. N. S., Jungo, P., Cajacob, L., Schwegler, S., Steveling, E. H., Manjaly Thomas, Z. R., Fuchs, O., Navarini, A., Scherer, K. and Brandt, O. (2020) ‘Fiction, falsehoods, and few facts: cross-sectional study on the content-related quality of atopic eczema-related videos on YouTube’, Journal of Medical Internet Research, 22(4), p. 15599

Huang, Y.-L., Liang, C.-Y., Ritz, D., Coelho, R., Septiadi, D., Estermann, M., Cumin, C., Rimmer, N., Schötzau, A., Núñez López, M., Fedier, A., Konantz, M., Vlajnic, T., Calabrese, D., Lengerke, C., David, L., Rothen-Rutishauser, B., Jacob, F. and Heinzelmann-Schwarz, V. (2020) ‘Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis’, eLife, 9, p. e59442

Castro, C. N., Rosenzwajg, M., Carapito, R., Shahrooei, M., Konantz, M., Khan, A., Miao, Z., Groß, M., Tranchant, T., Radosavljevic, M., Paul, N., Stemmelen, T., Pitoiset, F., Hirschler, A., Nespola, B., Molitor, A., Rolli, V., Pichot, A., Faletti, L. E., Rinaldi, B., Friant, S., Mednikov, M., Karauzum, H., Aman, M. J., Carapito, C., Lengerke, C., Ziaee, V., Eyaid, W., Ehl, S., Alroqi, F., Parvaneh, N. and Bahram, S. (2020) ‘NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation’, The Journal of Experimental Medicine, 217(12), p. e20192275

Hamarsheh, S., Osswald, L., Saller, B. S., Unger, S., De Feo, D., Vinnakota, J. M., Konantz, M., Uhl, F. M., Becker, H., Lübbert, M., Shoumariyeh, K., Schürch, C., Andrieux, G., Venhoff, N., Schmitt-Graeff, A., Duquesne, S., Pfeifer, D., Cooper, M. A., Lengerke, C., Boerries, M., Duyster, J., Niemeyer, C. M., Erlacher, M., Blazar, B. R., Becher, B., Groß, O., Brummer, T. and Zeiser, R. (2020) ‘Oncogenic Kras; G12D; causes myeloproliferation via NLRP3 inflammasome activation’, Nature Communications, 11(1), p. 1659

Schürch, C., Schaefer, T., Müller, J. S., Hanns, P., Arnone, M., Dumlin, A., Schärer, J., Sinning, I., Wild, K., Skokowa, J., Welte, K., Carapito, R., Bahram, S., Konantz, M. and Lengerke, C. (2020) ‘SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing’, Blood, 137(10), pp. 1340-1352

Arnone, M., Konantz, M., Hanns, P., Paczulla Stanger, A. M., Bertels, S., Godavarthy, P. S., Christopeit, M. and Lengerke, C. (2020) ‘Acute myeloid leukemia stem cells: the challenges of phenotypic heterogeneity’, Cancers, 12(12), p. cancers12123742

Hoof I., Schulten V., Layhadi J. A., Stranzl T., Christensen L. H., Herrera de la Mata S., Seumois G., Vijayanand P., Lundegaard C., Niss K., Lund A., Ahrenfeldt J., Holm J., Steveling E., Sharif H., Durham S. R., Peters B., Shamji M. H. and Andersen P. S. (2020) ‘Allergen-specific IgG⁺ memory B cells are temporally linked to IgE memory responses’, Journal of Allergy and Clinical Immunology, 146(1), pp. 180-191

Jamiolkowski D., Mühleisen B., Müller S., Navarini A. A., Tzankov A. and Roider E. (2020) ‘SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report’, Lancet, 396(10251), pp. 598-599

2019

Sperr, W. R., Kundi, M., Alvarez-Twose, I., van Anrooij, B., Oude Elberink, J. N. G., Gorska, A., Niedoszytko, M., Gleixner, K. V., Hadzijusufovic, E., Zanotti, R., Bonadonna, P., Bonifacio, M., Perkins, C., Illerhaus, A., Elena, C., Merante, S., Shoumariyeh, K., von Bubnoff, N., Parente, R., Jawhar, M., Belloni Fortina, A., Caroppo, F., Brockow, K., Zink, A., Fuchs, D., Kilbertus, A. J., Yavuz, A. S., Doubek, M., Hägglund, H., Panse, J., Sabato, V., Bretterklieber, A., Niederwieser, D., Breynaert, C., Hartmann, K., Triggiani, M., Nedoszytko, B., Reiter, A., Orfao, A., Hermine, O., Gotlib, J., Arock, M., Kluin-Nelemans, H. C. and Valent, P. (2019) ‘International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study’, The Lancet. Haematology, 6(12), pp. e638-e649

Kaesler, S., Wölbing, F., Kempf, W. E., Skabytska, Y., Köberle, M., Volz, T., Sinnberg, T., Amaral, T., Möckel, S., Yazdi, A., Metzler, G., Schaller, M., Hartmann, K., Weide, B., Garbe, C., Rammensee, H.-G., Röcken, M. and Biedermann, T. (2019) ‘Targeting tumor-resident mast cells for effective anti-melanoma immune responses’, JCI insight, 4(19), p. e125057

Bork, K., Aygören-Pürsün, E., Bas, M., Biedermann, T., Greve, J., Hartmann, K., Magerl, M., Martinez-Saguer, I., Maurer, M., Ott, H., Schauf, L., Staubach, P. and Wedi, B. (2019) ‘Guideline: Hereditary angioedema due to C1 inhibitor deficiency. S1 Guideline of the German Society for Angioedema (Deutsche Gesellschaft für Angioödeme, DGA), German Society for Internal Medicine (Deutsche Gesellschaft für Innere Medizin, DGIM), German Society for Otorhinolaryngology (Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, DGHNO), German Society for Allergology and Clinical Immunology (Deutsche Gesellschaft für Allergologie und klinische Immunologie, DGAKI), German Society for Child and Adolescent Medicine (Deutsche Gesellschaft für Kinder- und Jugendmedizin, DGKJ), German Dermatological Society (Deutsche Dermatologische Gesellschaft, DDG), German Society for Pediatric Allergology and Environmental Medicine (Gesellschaft für Pädiatrische Allergologie und Umweltmedizin, GPA), German Association of ENT Surgeons (Deutscher Berufsverband der Hals-Nasen-Ohren-Ärzte, BVHNO), and the German HAE Patient Association (HAE-Vereinigung, Selbsthilfegruppe, HAE-SHG)’, Allergo Journal International, 28(1), pp. 16-29

Williams, M., Lidke, D. S., Hartmann, K. and George, T. I. (2019) ‘PD-L1 expression in mastocytosis’, International Journal of Molecular Sciences, 20(9), p. E2362

Valent, P., Oude Elberink, J. N. G., Gorska, A., Lange, M., Zanotti, R., van Anrooij, B., Bonifacio, M., Bonadonna, P., Gleixner, K. V., Hadzijusufovic, E., Perkins, C., Hartmann, K., Illerhaus, A., Merante, S., Elena, C., Shoumariyeh, K., von Bubnoff, N., Parente, R., Triggiani, M., Schwaab, J., Jawhar, M., Caroppo, F., Fortina, A. B., Brockow, K., Hematology, Oncology, K. U. H., Johannes Kepler University, L., Austria., Greul, R., Yavuz, A. S., Doubek, M., Mattsson, M., Hagglund, H., Panse, J., Sabato, V., Aberer, E., Al-Ali, H. K., Morren, M.-A., Varkonyi, J., Zink, A., Niedoszytko, M., Niederwieser, D., Malcovati, L., Reiter, A., Kennedy, V., Gotlib, J., Lortholary, O., Hermine, O., Arock, M., Kluin-Nelemans, H., Sperr, W. R. and Study Group of the European Competence Network on Mastocytosis (2019) ‘The data registry of the European Competence Network on Mastocytosis (ECNM): set up, projects, and perspectives’, The Journal of Allergy and Clinical Immunology. In Practice, 7(1), pp. 81-87

Hagemann, P. M., Nsiah-Dosu, S., Hundt, J. E., Hartmann, K. and Orinska, Z. (2019) ‘Modulation of mast cell reactivity by lipids: the neglected side of allergic diseases’, Frontiers in Immunology, 10, p. 1174

Recke, A., Massalme, E. G., Jappe, U., Steinmüller-Magin, L., Schmidt, J., Hellenbroich, Y., Hüning, I., Gillessen-Kaesbach, G., Zillikens, D. and Hartmann, K. (2019) ‘Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema’, Clinical and Translational Allergy, 9, p. 9

Valent, P., Bonadonna, P., Hartmann, K., Broesby-Olsen, S., Brockow, K., Butterfield, J. H., Triggiani, M., Lyons, J. J., Oude Elberink, J. N. G., Arock, M., Metcalfe, D. D. and Akin, C. (2019) ‘Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome’, International Archives of Allergy and Immunology, 180(1), pp. 44-51

Knuever, J., Persa, O. D., Illerhaus, A., Ralser, D. J., Hartmann, K., Betz, R. C. and Tantcheva-Poór, I. (2019) ‘Mast cell activation in Dowling-Degos disease’, The British Journal of Dermatology, 181(6), pp. 1312-1314

Untersmayr, E., Bax, H. J., Bergmann, C., Bianchini, R., Cozen, W., Gould, H. J., Hartmann, K., Josephs, D. H., Levi-Schaffer, F., Penichet, M. L., O’Mahony, L., Poli, A., Redegeld, F. A., Roth-Walter, F., Turner, M. C., Vangelista, L., Karagiannis, S. N. and Jensen-Jarolim, E. (2019) ‘AllergoOncology: microbiota in allergy and cancer - a European Academy for Allergy and Clinical Immunology position paper’, Allergy, 74(6), pp. 1037-1051

Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., Butterfield, J. H., Alvarez-Twose, I., Sotlar, K., Reiter, A., Kluin-Nelemans, H. C., Hermine, O., Gotlib, J., Broesby-Olsen, S., Orfao, A., Horny, H.-P., Triggiani, M., Arock, M., Schwartz, L. B. and Metcalfe, D. D. (2019) ‘Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome’, The Journal of Allergy and Clinical Immunology. In Practice, 7(4), pp. 1125-1133

Francuzik, W., Dölle-Bierke, S., Knop, M., Scherer Hofmeier, K., Cichocka-Jarosz, E., García, B. E., Lang, R., Maris, I., Renaudin, J. M. and Worm, M. (2019) ‘Refractory anaphylaxis: data from the European Anaphylaxis Registry’, Frontiers in Immunology, 10, article nr. 2482

Bircher, A. J., Scherer Hofmeier, K., Schlegel, U. and Hauri, U. (2019) ‘Genipin in temporary jagua tattoos - black dye causing severe allergic dermatitis', Dermatitis, 30(6), pp. 375-376

Scherer Hofmeier, K. (2019) ‘Allergien gegen Nicht-Betalaktam-Antibiotika: eine Herausforderung in der Praxis’, Therapeutische Umschau, 75(1), pp. 13-21

Garvey, L. H., Dewachter, P., Hepner, D. L., Mertes, P. M., Voltolini, S., Clarke, R., Cooke, P., Garcez, T., Guttormsen, A. B., Ebo, D. G., Hopkins, P. M., Khan, D. A., Kopac, P., Krøigaard, M., Laguna, J. J., Marshall, S., Platt, P., Rose, M., Sabato, V., Sadleir, P., Savic, L., Savic, S., Scherer, K., Takazawa, T., Volcheck, G. W. and Kolawole, H. (2019) ‘Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations’, British Journal of Anaesthesia, 123(1), pp. e50-e64

Garvey, L. H., Ebo, D. G., Mertes, P. M., Dewachter, P., Garcez, T., Kopac, P., Laguna, J. J., Chiriac, A. M., Terreehorst, I., Voltolini, S. and Scherer, K. (2019) ‘An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions’, Allergy, 74(10), pp. 1872-1884

Muller, Y. D., Vionnet, J., Beyeler, F., Eigenmann, P., Caubet, J. C., Villard, J., Berney, T., Scherer, K., Spertini, F., Fricker, M. P., Lang, C., Schmid-Grendelmeier, P., Benden, C., Roux Lombard, P., Aubert, V., Immer, F., Pascual, M. and Harr, T. (2019) ‘Management of allergy transfer upon solid organ transplantation’, American Journal of Transplantation, 20(3), pp. 834-843

Aurich, S., Dölle-Bierke, S., Francuzik, W., Bilo, M. B., Christoff, G., Fernandez-Rivas, M., Hawranek, T., Pföhler, C., Poziomkowska-Gȩsicka, I., Renaudin, J. M., Oppel, E., Scherer, K., Treudler, R. and Worm, M. (2019) ‘Anaphylaxis in elderly patients-data from the European Anaphylaxis Registry’, Frontiers in Immunology, 10, p. 750

Garvey, L. H., Ebo, D. G., Krøigaard, M., Savic, S., Clarke, R., Cooke, P., Dewachter, P., Garcez, T., Guttormsen, A. B., Hopkins, P. M., Hepner, D. L., Khan, D. A., Kolawole, H., Kopac, P., Marshall, S., Mertes, P. M., Platt, P., Rose, M., Sabato, V., Sadleir, P., Savic, L., Scherer, K., Takazawa, T., Volcheck, G. W., Voltolini, S. and Laguna, J. J. (2019) ‘The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status’, British Journal of Anaesthesia, 123(1), pp. 126-134

Krisai, P., Rudin, D., Grünig, D., Scherer, K., Pichler, W., Terracciano, L. and Krähenbühl, S. (2019) ‘Acute liver failure in a patient treated with metamizole’, Frontiers in Pharmacology, 10, p. 996

Brockhaus, L., Schmid, Y., Rast, A. C., Rätz Bravo, A. E., Scherer Hofmeier, K. and Leuppi-Taegtmeyer, A. B. (2019) ‘Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports’, BMC Pharmacology and Toxicology, 20(1), p. 9

Konantz, M., Müller, J. S. and Lengerke, C. (2019) ‘Zebrafish xenografts for the in vivo analysis of healthy and malignant human hematopoietic cells’, Methods in Molecular Biology, 2017, pp. 205-217

Hanns, P., Paczulla, A. M., Medinger, M., Konantz, M. and Lengerke, C. (2019) ‘Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis’, Cell Stress, 3(7), pp. 221-235

Konantz, M., Schürch, C., Hanns, P., Müller, J. S., Sauteur, L. and Lengerke, C. (2019) ‘Modeling hematopoietic disorders in zebrafish’, Disease Models & Mechanisms, 12(9), p. dmm040360

Paczulla, A. M., Rothfelder, K., Raffel, S., Konantz, M., Steinbacher, J., Wang, H., Tandler, C., Mbarga, M., Schaefer, T., Falcone, M., Nievergall, E., Dörfel, D., Hanns, P., Passweg, J. R., Lutz, C., Schwaller, J., Zeiser, R., Blazar, B. R., Caligiuri, M. A., Dirnhofer, S., Lundberg, P., Kanz, L., Quintanilla-Martinez, L., Steinle, A., Trumpp, A., Salih, H. R. and Lengerke, C. (2019) ‘Publisher correction: absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion’, Nature, 572(7770), p. E19

Paczulla, A. M., Rothfelder, K., Raffel, S., Konantz, M., Steinbacher, J., Wang, H., Tandler, C., Mbarga, M., Schaefer, T., Falcone, M., Nievergall, E., Dörfel, D., Hanns, P., Passweg, J. R., Lutz, C., Schwaller, J., Zeiser, R., Blazar, B. R., Caligiuri, M. A., Dirnhofer, S., Lundberg, P., Kanz, L., Quintanilla-Martinez, L., Steinle, A., Trumpp, A., Salih, H. R. and Lengerke, C. (2019) ‘Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion’, Nature, 572(7768), pp. 254-259

Shamij, M. H., Abubakar-Waziri, H., Zhang, J., Steveling-Klein, E. H., Watchman, S., Kouser, L., Eifan, A., Switzer, A., Varrichi, G., Marone, G., Couto Francisco, N. C., Calderon, M. and Durham, S. R. (2019) ‘Nasal allergen neutralising IgG4 antibodies block IgE-mediated responses: novel biomarker of subcutaneous grass pollen immunotherapy’, The Journal of Allergy and Clinical Immunology, 143(3), pp. 1067-1076

Wienke, J., Bellutti Enders, F., Lim, J., Mertens, J. S., van den Hoogen, L. L., Wijngaarde, C. A., Yeo, J. G., Meyer, A., Otten, H. G., Fritsch-Stork, R. D. E., Kamphuis, S. S. M., Hoppenreijs, E. P. A. H., Armbrust, W., van den Berg, M., Hissink Muller, P. C. E., Tekstra, J., Hoogendijk, J. E., Deakin, C. T., de Jager, W., van Roon, J. A. G., van der Pol, L. W., Nistala, K., Pilkington, C., de Visser, M., Arkachaisri, T., Radstake, T. R. D. J., van der Kooi, A. J., Nierkens, S., Wedderburn, L. R., van Royen-Kerkhof, A. and van Wijk, F. (2019) ‘Galectin-9 and CXCL-10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multi-cohort validation’, Arthritis & Rheumatology,71(8), pp. 1377-1390

Battaglia, M., Furlong, P., Wulffraat, N. M. and Bellutti Enders, F. (2019) ‘Improving the translational medicine process: moving patients from "end-users" to "engaged collaborators"’, Frontiers of Medicine 6, p. 110

Pröbstel A. K., Thanei M., Erni B., Lecourt A. C., Branco L., André R., Roux-Lombard P., Koenig K. F., Huynh-Do U., Ribi C., Chizzolini C., Kappos L., Trendelenburg M. and Derfuss T.; Swiss Systemic Lupus Erythematosus Cohort Study Group (2019) ‘Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus’, Rheumatology (Oxford), 58(5), pp. 908-913

2018

Hartmann, K., Valent, P. and Horny, H.-P. (2018) ‘Cutaneous mastocytosis’, in Elder, D. E., Massi, D., Scolyer, R., and Willemze, R. (eds) World Health Organization (WHO) Classification of Skin Tumours. Lyon: International Agency for Research on Cancer, pp. 275-278

Arock, M., Wedeh, G., Hoermann, G., Bibi, S., Akin, C., Peter, B., Gleixner, K. V., Hartmann, K., Butterfield, J. H., Metcalfe, D. D. and Valent, P. (2018) ‘Preclinical human models and emerging therapeutics for advanced systemic mastocytosis’, Haematologica, 103(11), pp. 1760-1771

Ghouse, S. M., Polikarpova, A., Muhandes, L., Dudeck, J., Tantcheva-Poór, I., Hartmann, K., Lesche, M., Dahl, A., Eming, S., Müller, W., Behrendt, R. and Roers, A. (2018) ‘Although abundant in tumor tissue, mast cells have no effect on immunological micro-milieu or growth of HPV-induced or transplanted tumors’, Cell Reports, 22(1), pp. 27-35

Yu, X., Kasprick, A., Hartmann, K. and Petersen, F. (2018) ‘The role of mast cells in autoimmune bullous dermatoses’, Frontiers in Immunology, 9, p. 386

Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Broesby-Olsen, S., Brockow, K., Butterfield, J. H., Reiter, A., Gotlib, J., Castells, M., Milner, J. D., Carter, M. C., Komarow, H., Radia, D., Pardanani, A., Sotlar, K., Triggiani, M., Horny, H.-P., Arock, M., Schwartz, L. B. and Metcalfe, D. D. (2018) ‘Mast cell activation syndrome: importance of consensus criteria and call for research’, The Journal of Allergy and Clinical Immunology, 142(3), pp. 1008-1010

Hatch, E. W., Geeze, M. B., Martin, C., Salama, M. E., Hartmann, K., Eisenwort, G., Blatt, K., Valent, P., Gotlib, J., Lee, J.-H., Chen, L., Ward, H. H., Lidke, D. S. and George, T. I. (2018) ‘Variability of PD-L1 expression in mastocytosis’, Blood Advances, 2(3), pp. 189-199

Wei, Y., Chhiba, K. D., Zhang, F., Ye, X., Wang, L., Zhang, L., Robida, P. A., Moreno-Vinasco, L., Schnaar, R. L., Roers, A., Hartmann, K., Lee, C.-M., Demers, D., Zheng, T., Bochner, B. S. and Zhu, Z. (2018) ‘Mast cell-specific expression of human Siglec-8 in conditional knock-in mice’, International Journal of Molecular Sciences, 20(1), p. 19

Magnúsdóttir, E. I., Grujic, M., Roers, A., Hartmann, K., Pejler, G. and Lagerström, M. C. (2018) ‘Mouse mast cells and mast cell proteases do not play a significant role in acute tissue injury pain induced by formalin’, Molecular Pain, 14, p. 1744806918808161

Rüdrich, U., Gehring, M., Papakonstantinou, E., Illerhaus, A., Engmann, J., Kapp, A., Hartmann, K., Meyer, N. H., Gibbs, B. F. and Raap, U. (2018) ‘Eosinophils are a major source of interleukin-31 in bullous pemphigoid’, Acta Dermato-Venereologica, 98(8), pp. 766-771

de Brito, M., Huebner, G., Murrell, D., Bullpitt, P. and Hartmann, K. (2018) ‘Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab’, Clinical and Translational Allergy, 8, p. 37

Furrer, S., Scherer Hofmeier, K., Grize, L. and Bircher, A. J. (2018) ‘Metal hypersensitivity in patients with orthopaedic implant complications - a retrospective clinical study’, Contact Dermatitis, 79(2), pp. 91-98

Spoerri, I., Bircher, A. J., Link, S., Heijnen, I. A. F. M. and Scherer Hofmeier, K. (2018) ‘Delayed-type allergy to cobalt - comparison of a flow cytometric lymphocyte proliferation test with patch testing’, Contact Dermatitis, 79(1), pp. 31-33

Worm, M., Francuzik, W., Renaudin, J. M., Bilo, M. B., Cardona, V., Scherer Hofmeier, K., Köhli, A., Bauer, A., Christoff, G., Cichocka-Jarosz, E., Hawranek, T., Hourihane, J. O. , Lange, L., Mahler, V., Muraro, A., Papadopoulos, N. G., Pföhler, C., Poziomkowska-Gesicka, I., Ruëff, F., Spindler, T., Treudler, R., Fernandez-Rivas, M. and Dölle S. (2018) ‘Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European Anaphylaxis Registry’, Allergy, 73(6), pp. 1322-1330

Grabenhenrich, L. B., Dölle, S., Ruëff, F., Renaudin, J. M., Scherer, K., Pföhler, C., Treudler, R., Koehli, A., Mahler, V., Spindler, T., Lange, L., Bilò, M. B., Papadopoulos, N. G., Hourihane, J. O. B., Lang, R., Fernández-Rivas, M., Christoff, G., Cichocka-Jarosz, E. and Worm, M. (2018) ‘Epinephrine in severe allergic reactions: the European Anaphylaxis Register’, The Journal of Allergy and Clinical Immunology: In Practice, 6(6), pp. 1898-1906

Hübner, S. T., Bertoli, R., Rätz Bravo, A. E., Schaueblin, M., Haschke, M., Scherer, K., Ceschi, A. and Leuppi-Taegtmeyer, A. B. (2018) ‘C-reactive protein and procalcitonin in case reports of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome’, International Archives of Allergy and Immunology, 176(1), pp. 44-54

Recher, M., Hirsiger, J. R., Bigler, M. B., Iff, M., Lemaître, B., Scherer, K., Häusermann, P., Siegrist, C. A. and Berger, C. T. (2018) ‘Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination’, NPJ Vaccines, 3, p. 17

Radonjic-Hoesli, S., Scherer Hofmeier, K., Micaletto, S., Schmid-Grendelmeier, P., Bircher, A. and Simon, D. (2018) ‘Urticaria and angioedema: an update on classification and pathogenesis’, Clinical Reviews in Allergy & Immunology, 54(1), pp. 88-101

Wang, H., Paczulla, A. M., Konantz, M. and Lengerke, C. (2018) ‘In vitro tumorigenic assay: the tumor spheres assay’, Methods in Molecular Biology, 1692, pp. 77-87

Jacob, F., Alam, S., Konantz, M., Liang, C.-Y., Kohler, R. S., Everest-Dass, A. V., Huang, Y.-L., Rimmer, N., Fedier, A., Schötzau, A., Lopez, M. N., Packer, N. H., Lengerke, C. and Heinzelmann-Schwarz, V. (2018) ‘Transition of mesenchymal and epithelial cancer cells depends on α1-4 galactosyltransferase-mediated glycosphingolipids’, Cancer Research, 78(11), pp. 2952-2965

2017

Valent, P., Akin, C., Hartmann, K., Nilsson, G., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T. I., Kluin-Nelemans, H. C., Ustun, C., Triggiani, M., Brockow, K., Gotlib, J., Orfao, A., Schwartz, L. B., Broesby-Olsen, S., Bindslev-Jensen, C., Kovanen, P. T., Galli, S. J., Austen, K. F., Arber, D. A., Horny, H.-P., Arock, M. and Metcalfe, D. D. (2017) ‘Advances in the classification and treatment of mastocytosis: current status and outlook toward the future’, Cancer Research, 77(6), pp. 1261-1270

Valent, P., Sotlar, K., Blatt, K., Hartmann, K., Reiter, A., Sadovnik, I., Sperr, W. R., Bettelheim, P., Akin, C., Bauer, K., George, T. I., Hadzijusufovic, E., Wolf, D., Gotlib, J., Mahon, F.-X., Metcalfe, D. D., Horny, H.-P. and Arock, M. (2017) ‘Proposed diagnostic criteria and classification of basophilic leukemias and related disorders’, Leukemia, 31(4), pp. 788-797

Valent, P., Akin, C., Hartmann, K., George, T. I., Sotlar, K., Peter, B., Gleixner, K. V., Blatt, K., Sperr, W. R., Manley, P. W., Hermine, O., Kluin-Nelemans, H. C., Arock, M., Horny, H.-P., Reiter, A. and Gotlib, J. (2017) ‘Midostaurin: a magic bullet that blocks mast cell expansion and activation’, Annals of Oncology, 28(10), pp. 2367-2376

Bircher, A. J., Sigg, R., Scherer Hofmeier, K., Schlegel, U. and Hauri, U. (2017) ‘Allergic contact dermatitis caused by a new temporary blue-black tattoo dye-sensitization to genipin from jagua (Genipa americana L.) fruit extract’, Contact Dermatitis, 77(6), pp. 374-378

Morales Mateluna, C. A., Scherer Hofmeier, K. and Bircher, A. J. (2017) ‘Approach to hypersensitivity reactions from intravenous iron preparations’, Allergy, 72(5), pp. 827-830

Bircher, A. J., Scherer Hofmeier, K., Link, S. and Heijnen, I. (2017) ‘Food allergy to the carbohydrate galactose-alpha-1,3-galactose (alpha-gal): four case reports and a review’, European Journal of Dermatology, 27(1), pp. 3-9

Worm, M., Scherer, K., Köhli-Wiesner, A., Ruëff, F., Mahler, V., Lange, L., Treudler, R., Rietschel, E., Szepfalusi, Z., Lang, R., Rabe, U., Reese, T., Schwerk, N., Beyer, K., Hompes, S., Bircher, A., Przybilla, B., Hawranek, T., Hansen, G., Friedrichs, F., Merk, H., Tenbrock, K., Lehmann, S., Gerstlauer, M., Kleine-Tebbe, J., Niggemann, B., Dickel, H., Bücheler, M., Bieber, T., Hanfland, J., Schmitt-Grohe, S., Vlajnic, D., Heckmann, V., Nemat, K., Schäkel, K., Nordwig, A., Schuster, A., Schweitzer-Krantz, S., Hillen, U., Kopp, M., Szliska, C., Klinge, J., Neustädter, I., Fuchs, T., Bruns, R., Marsch, C., Kreft, B., Coors, E., Rebien, W., Wedi, B., Pföhler, C., Rett, M., Henzgen, M., Vöhringer, P., Fölster-Holst, R., Hunzelmann, N., Siebenhaar, G., Nestoris, S., Schirpke, C., Grabbe, J., Stichtenoth, G., Ring, J., Brockow, K., Brehler, R., Yildiz, I., Volkmuth, S., Geißler, M., Polz, M., Riffelmann, F., Thies, S., Lepp, U., Rabe, U., Rebmann, H., Spindler, T., Klimek, L., Pfaar, O., Brosi, W., Aberer, W., Varga, E., Reider, N., Huttegger, I., Kinaciyan, T., Hoffmann-Sommergruber, K., Eng, P., Helbling, A., Eigenmann, P., Guggenheim, R. and Schmid-Grendelmeier, P. (2017) ‘Food-induced anaphylaxis and cofactors - data from the anaphylaxis registry’, Allergologie Select, 1(1), pp.21-27

Queisser, A., Hagedorn, S., Wang, H., Schaefer, T., Konantz, M., Alavi, S., Deng, M., Vogel, W., von Mässenhausen, A., Kristiansen, G., Duensing, S., Kirfel, J., Lengerke, C. and Perner, S. (2017) ‘Ecotropic viral integration site 1, a novel oncogene in prostate cancer’, Oncogene, 36(11), pp. 1573-1584

Paczulla, A. M., Dirnhofer, S., Konantz, M., Medinger, M., Salih, H. R., Rothfelder, K., Tsakiris, D. A., Passweg, J. R., Lundberg, P. and Lengerke, C. (2017) ‘Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice’, Haematologica, 102(5), pp. 854-864

Wang, H., Schaefer, T., Konantz, M., Braun, M., Varga, Z., Paczulla, A. M., Reich, S., Jacob, F., Perner, S., Moch, H., Fehm, T. N., Kanz, L., Schulze-Osthoff, K. and Lengerke, C. (2017) ‘Prominent oncogenic roles of EVI1 in breast carcinoma’, Cancer Research, 77(8), pp. 2148-2160

Carapito, R., Konantz, M., Paillard, C., Miao, Z., Pichot, A., Leduc, M. S., Yang, Y., Bergstrom, K. L., Mahoney, D. H., Shardy, D. L., Alsaleh, G., Naegely, L., Kolmer, A., Paul, N., Hanauer, A., Rolli, V., Müller, J. S., Alghisi, E., Sauteur, L., Macquin, C., Morlon, A., Sancho, C. S., Amati-Bonneau, P., Procaccio, V., Mosca-Boidron, A.-L., Marle, N., Osmani, N., Lefebvre, O., Goetz, J. G., Unal, S., Akarsu, N. A., Radosavljevic, M., Chenard, M.-P., Rialland, F., Grain, A., Béné, M.-C., Eveillard, M., Vincent, M., Guy, J., Faivre, L., Thauvin-Robinet, C., Thevenon, J., Myers, K., Fleming, M. D., Shimamura, A., Bottollier-Lemallaz, E., Westhof, E., Lengerke, C., Isidor, B. and Bahram, S. (2017) ‘Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features’, The Journal of Clinical Investigation, 127(11), pp. 4090-4103

Bellutti Enders, F., Bader-Meunier, B., Baildam, E., Constantin, T., Dolezalova, P., Feldman, B. M., Lahdenne, P., Magnusson, B., Nistala, K., Ozen, S., Pilkington, C., Ravelli, A., Russo, R., Uziel, Y., van Brussel, M., van der Net, J., Vastert, S., Wedderburn, L. R., Wulffraat, N., McCann, L. J. and van Royen-Kerkhof, A.(2017) ‘Consensus-based recommendations for the management of juvenile dermatomyositis’, Annals of Rheumatic Diseases, 76(2), pp. 329-340

2016

Öhrvik, H., Grujic, M., Waern, I., Gustafson, A.-M., Ernst, N., Roers, A., Hartmann, K. and Pejler, G. (2016) ‘Mast cells promote melanoma colonization of lungs’, Oncotarget, 7(42), pp. 68990-69001

Ochsendorf, F., Bandholz, T., Emmert, S., Hartmann, K., Hartmann, M., Hornung, T., Jünger, M., Kollewe, T., Löser, C., Moll, I., Psotta-Schachtner, C., Spornraft-Ragaller, P., Ständer, S., von Stebut-Borschitz, E. and Hamm, H. (2016) ‘111 Top-Lernziele Dermatologie: Lernzielkatalog für Haut- und Geschlechtskrankheiten der Deutschen Dermatologischen Gesellschaft’, Journal der Deutschen Dermatologischen Gesellschaft, 14(6), pp. 637-643

Rabenhorst, A., Leja, S., Schwaab, J., Gehring, M., Förster, A., Arock, M., Reiter, A., Raap, U. and Hartmann, K. (2016) ‘Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity’, The Journal of Allergy and Clinical Immunology, 137(1), pp. 314-318

El Beidaq, A., Link, C. W. M., Hofmann, K., Frehse, B., Hartmann, K., Bieber, K., Martin, S. F., Ludwig, R. J. and Manz, R. A. (2016) ‘In vivo expansion of endogenous regulatory T cell populations induces long-term suppression of contact hypersensitivity’, Journal of Immunology, 197(5), pp. 1567-1576

Hartmann, K., Escribano, L., Grattan, C., Brockow, K., Carter, M. C., Alvarez-Twose, I., Matito, A., Broesby-Olsen, S., Siebenhaar, F., Lange, M., Niedoszytko, M., Castells, M., Oude Elberink, J. N. G., Bonadonna, P., Zanotti, R., Hornick, J. L., Torrelo, A., Grabbe, J., Rabenhorst, A., Nedoszytko, B., Butterfield, J. H., Gotlib, J., Reiter, A., Radia, D., Hermine, O., Sotlar, K., George, T. I., Kristensen, T. K., Kluin-Nelemans, H. C., Yavuz, S., Hägglund, H., Sperr, W. R., Schwartz, L. B., Triggiani, M., Maurer, M., Nilsson, G., Horny, H.-P., Arock, M., Orfao, A., Metcalfe, D. D., Akin, C. and Valent, P. (2016) ‘Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology’, The Journal of Allergy and Clinical Immunology, 137(1), pp. 35-45

Siebenhaar, F., von Tschirnhaus, E., Hartmann, K., Rabenhorst, A., Staubach, P., Peveling-Oberhag, A., Wagner, N., Martus, P., Carter, M. C., Metcalfe, D. D., Church, M. K., Maurer, M. and Weller, K. (2016) ‘Development and validation of the mastocytosis quality of life questionnaire: MC-QoL’, Allergy, 71(6), pp. 869-877

Gotlib, J., Kluin-Nelemans, H. C., George, T. I., Akin, C., Sotlar, K., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Sternberg, D. W., Villeneuve, M., Huntsman Labed, A., Stanek, E. J., Hartmann, K., Horny, H.-P., Valent, P. and Reiter, A. (2016) ‘Efficacy and safety of midostaurin in advanced systemic mastocytosis’, The New England Journal of Medicine, 374(26), pp. 2530-2541

Ustun, C., Arock, M., Kluin-Nelemans, H. C., Reiter, A., Sperr, W. R., George, T., Horny, H.-P., Hartmann, K., Sotlar, K., Damaj, G., Hermine, O., Verstovsek, S., Metcalfe, D. D., Gotlib, J., Akin, C. and Valent, P. (2016) ‘Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice’, Haematologica, 101(10), pp. 1133-1143

Theurich, S., Schlaak, M., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Rabenhorst, A., Hartmann, K., Schlösser, H., Shimabukuro-Vornhagen, A., Holtick, U., Hallek, M., Stadler, R. and von Bergwelt-Baildon, M. (2016) ‘Targeting tumor-infiltrating B cells in cutaneous T-cell lymphoma’, Journal of Clinical Oncology, 34(12), pp. e110-116

Terrani, I., Bircher, A. J. and Scherer Hofmeier, K. (2016) ‘Solar urticaria induced by visible light: successful treatment with omalizumab’, Clinical and Experimental Dermatology, 41(8), pp. 890 - 892

Grabenhenrich, L. B., Dölle, S., Moneret-Vautrin, A., Köhli, A., Lange, L., Spindler, T., Ruëff, F., Nemat, K., Maris, I., Roumpedaki, E., Scherer, K., Ott, H., Reese, T., Mustakov, T., Lang, R., Fernandez-Rivas, M., Kowalski, M. L., Bilò, M. B., Hourihane, J. O., Papadopoulos, N. G., Beyer, K., Muraro, A. and Worm, M. (2016) ‘Anaphylaxis in children and adolescents: the European Anaphylaxis Registry’, Journal of Allergy and Clinical Immunology, 137(4), pp. 1128-1137

Cesana, P., Scherer, K. and Bircher, A. J. (2016) ‘Immediate type hypersensitivity to heparins: two case reports and a review of the literature’, International Archives of Allergy and Immunology, 171(3-4), pp. 285-289

Steiner, U. C., Weber-Chrysochoou, C., Helbling, A., Scherer, K., Grendelmeier, P. S. and Wuillemin, W. A. (2016) ‘Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study’, Orphanet Journal of Rare Diseases, 11, p. 43

Kanz, D., Konantz, M., Alghisi, E., North, T. E. and Lengerke, C. (2016) ‘Endothelial-to-hematopoietic transition: notch-ing vessels into blood’, Annals of the New York Academy of Sciences, 1370(1), pp. 97-108

von Mässenhausen, A., Sanders, C., Brägelmann, J., Konantz, M., Queisser, A., Vogel, W., Kristiansen, G., Duensing, S., Schröck, A., Bootz, F., Brossart, P., Kirfel, J., Lengerke, C. and Perner, S. (2016) ‘Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib’, International Journal of Cancer, 139(10), pp. 2359-2369

Konantz, M., Alghisi, E., Müller, J. S., Lenard, A., Esain, V., Carroll, K. J., Kanz, L., North, T. E. and Lengerke, C (2016) ‘Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence’, EMBO J 35(21), pp. 2315-2331

Steveling-Klein, E. H. (2016) ‘Allergen-specific immunotherapy’, European Medical Journal, 1(4), pp. 78-87

Enz, C., Brighenti-Zogg, S., Steveling-Klein, E. H., Dürr, S., Maier, S., Miedinger, D. and Leuppi, J. D. (2016) ‘Predictors of increased daytime sleepiness in patients with chronic obstructive pulmonary disease: a cross-sectional study’, Sleep Disorders, 2016, p. 1089196

Jamiolkowski, D., Kölker, S., Glahn, E. M., Baric, I., Zeman, J., Baumgartner, M. R., Mühlhausen, C., Garcia-Cazorla, A., Gleich, F., Haege, G., Burgard, P. and E-IMD consortium (2016) ‘Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders’, Journal of Inherited Metabolic Disease, 39(2), pp. 231-241

2015

Peschke, K., Dudeck, A., Rabenhorst, A., Hartmann, K. and Roers, A. (2015) ‘Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation’, Methods in Molecular Biology, 1220, pp. 403-421

Förster, A., Blissenbach, B., Machova, A., Leja, S., Rabenhorst, A., Wilmschen, S., Heger, K., Schmidt-Supprian, M., Roers, A., Hartmann, K. and Papadopoulou, N. (2015) ‘Dicer is indispensable for the development of murine mast cells’, The Journal of Allergy and Clinical Immunology, 135(4), pp. 1077-1080

Cerny-Reiterer, S., Rabenhorst, A., Stefanzl, G., Herndlhofer, S., Hoermann, G., Müllauer, L., Baumgartner, S., Beham-Schmid, C., Sperr, W. R., Mannhalter, C., Sill, H., Linkesch, W., Arock, M., Hartmann, K. and Valent, P. (2015) ‘Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia’, Oncotarget, 6(5), pp. 3071-3084

Drube, S., Weber, F., Loschinski, R., Beyer, M., Rothe, M., Rabenhorst, A., Göpfert, C., Meininger, I., Diamanti, M. A., Stegner, D., Häfner, N., Böttcher, M., Reinecke, K., Herdegen, T., Greten, F. R., Nieswandt, B., Hartmann, K., Krämer, O. H. and Kamradt, T. (2015) ‘Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells’, Oncotarget, 6(7), pp. 5354-5368

Förster, A., Grotha, S. P., Seeger, J. M., Rabenhorst, A., Gehring, M., Raap, U., Létard, S., Dubreuil, P., Kashkar, H., Walczak, H., Roers, A. and Hartmann, K. (2015) ‘Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells’, Allergy, 70(7), pp. 764-774

Arock, M., Sotlar, K., Akin, C., Broesby-Olsen, S., Hoermann, G., Escribano, L., Kristensen, T. K., Kluin-Nelemans, H. C., Hermine, O., Dubreuil, P., Sperr, W. R., Hartmann, K., Gotlib, J., Cross, N. C. P., Haferlach, T., Garcia-Montero, A., Orfao, A., Schwaab, J., Triggiani, M., Horny, H.-P., Metcalfe, D. D., Reiter, A. and Valent, P. (2015) ‘KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis’, Leukemia, 29(6), pp. 1223-1232

Wiechers, T., Rabenhorst, A., Schick, T., Preussner, L. M., Förster, A., Valent, P., Horny, H.-P., Sotlar, K. and Hartmann, K. (2015) ‘Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis’, The Journal of Allergy and Clinical Immunology, 136(6), pp. 1581-1590

Kasprick, A., Yu, X., Scholten, J., Hartmann, K., Pas, H. H., Zillikens, D., Ludwig, R. J. and Petersen, F. (2015) ‘Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita’, European Journal of Immunology, 45(5), pp. 1462-1470

Drube, S., Weber, F., Göpfert, C., Loschinski, R., Rothe, M., Boelke, F., Diamanti, M. A., Löhn, T., Ruth, J., Schütz, D., Häfner, N., Greten, F. R., Stumm, R., Hartmann, K., Krämer, O. H., Dudeck, A. and Kamradt, T. (2015) ‘TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases’, Oncotarget, 6(30), pp. 28833-28850

Scherer Hofmeier, K. and Bircher A. J. (2015) ‘Arzneimittelallergien: klinische Präsentation und Warnzeichen’, Therapeutische Umschau, 72(11-12), pp. 729 - 736

Spoerri, I., Scherer, K., Michel, S., Link, S., Bircher, A. J. and Heijnen, I. A. F. M. (2015) ‘Detection of nickel and palladium contact hypersensitivity by a flow cytometric lymphocyte proliferation test’, Allergy, 70(3), pp. 323-327

Berger, C. T., Baldi, T., Aschwanden, M., Scherer, K., Recher, M., Hess, C. and Daikeler, T. (2015) ‘Diagnosis at your fingertips: splinters and microemboli--is it SLE?’, Lupus, 24(3), pp. 341-342

Spoerri, I., Scherer, K., Michel, S., Link, S., Bircher, A. J. and Heijnen, I. A. (2015) ‘Detection of nickel and palladium contact hypersensitivity by a flow cytometric lymphocyte proliferation test’, Allergy, 70(3), pp. 323-327

Scherer Hofmeier, K. (2015) ‘Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs’, Allergo Journal International, 24(2), pp. 58-66

Schaefer, T., Wang, H., Mir, P., Konantz, M., Pereboom, T. C., Paczulla, A. M., Merz, B., Fehm, T., Perner, S., Rothfuss, O. C., Kanz, L., Schulze-Osthoff, K. and Lengerke, C. (2015) ‘Molecular and functional interactions between AKT and SOX2 in breast carcinoma’, Oncotarget, 6(41), pp. 43540-43556

Steveling, E. H., Lao-Araya, M., Koulias, C., Scadding, G., Eifan, A., James, L. K., Dumitru, A., Penagos, M., Calderón, M., Andersen, P. S., Shamji, M. and Durham, S. R. (2015) ‘Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes’, Clinical and Translational Allergy, 5, p. 43

Scadding, G. W., Eifan, A. O., Lao-Araya, M., Penagos, M., Poon, S. Y., Steveling, E. H., Yan, R., Switzer, A., Phippard, D., Togias, A., Shamji, M. H. and Durham, S. R. (2015) ‘Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge’, Allergy, 70(6), pp. 689-696

Bellutti Enders, F., Delemarre, E. M., Kuemmerle-Deschner, J., van der Torre, P., Wulffraat,N. M., Prakken,B. P., van Royen-Kerkhof, A. and van Wijk, F. (2015) ‘Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of patients with juvenile dermatomyositis correlating with disease activity’, Annals of Rheumatic Diseases, 74(1), pp. 315-317

2014

Valent, P., Escribano, L., Broesby-Olsen, S., Hartmann, K., Grattan, C., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, J. N. G., Kristensen, T., Butterfield, J. H., Triggiani, M., Alvarez-Twose, I., Reiter, A., Sperr, W. R., Sotlar, K., Yavuz, S., Kluin-Nelemans, H. C., Hermine, O., Radia, D., van Doormaal, J. J., Gotlib, J., Orfao, A., Siebenhaar, F., Schwartz, L. B., Castells, M., Maurer, M., Horny, H.-P., Akin, C., Metcalfe, D. D., Arock, M. and European Competence Network on Mastocytosis (2014) ‘Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis’, Allergy, 69(10), pp. 1267-1274

Willenborg, S., Eckes, B., Brinckmann, J., Krieg, T., Waisman, A., Hartmann, K., Roers, A. and Eming, S. A. (2014) ‘Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis’, The Journal of Investigative Dermatology, 134(7), pp. 2005-2015

Erben, P., Schwaab, J., Metzgeroth, G., Horny, H.-P., Jawhar, M., Sotlar, K., Fabarius, A., Teichmann, M., Schneider, S., Ernst, T., Müller, M. C., Giehl, M., Marx, A., Hartmann, K., Hochhaus, A., Hofmann, W.-K., Cross, N. C. P. and Reiter, A. (2014) ‘The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis’, Annals of Hematology, 93(1), pp. 81-88

Rönnberg, E., Johnzon, C.-F., Calounova, G., Garcia Faroldi, G., Grujic, M., Hartmann, K., Roers, A., Guss, B., Lundequist, A. and Pejler, G. (2014) ‘Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal S. aureus infection in vivo’, Immunology, 143(2), pp. 155-163

Rabenhorst, A. and Hartmann, K. (2014) ‘Interleukin-31: a novel diagnostic marker of allergic diseases’, Current Allergy and Asthma Reports, 14(4), p. 423

Valent, P., Sotlar, K., Sperr, W. R., Escribano, L., Yavuz, S., Reiter, A., George, T. I., Kluin-Nelemans, H. C., Hermine, O., Butterfield, J. H., Hägglund, H., Ustun, C., Hornick, J. L., Triggiani, M., Radia, D., Akin, C., Hartmann, K., Gotlib, J., Schwartz, L. B., Verstovsek, S., Orfao, A., Metcalfe, D. D., Arock, M. and Horny, H.-P. (2014) ‘Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal’, Annals of Oncology, 25(9), pp. 1691-1700

Peschke, K., Weitzmann, A., Heger, K., Behrendt, R., Schubert, N., Scholten, J., Voehringer, D., Hartmann, K., Dudeck, A., Schmidt-Supprian, M. and Roers, A. (2014) ‘IκB kinase 2 is essential for IgE-induced mast cell de novo cytokine production but not for degranulation’, Cell Reports, 8(5), pp. 1300-1307

Schneider Spence, J. A., Bircher, A. J. and Scherer Hofmeier, K. (2014) ‘Bedeutung der allergologischen Abklärung bei Asthma und COPD’, Therapeutische Umschau, 71(5), pp. 267-274

Bircher, A. J. and Scherer Hofmeier, K. (2014) ‘Tolerance induction in hypersensitivity reactions from drugs: a brief overview’, European Journal of Dermatology, 24(2), pp. 154-157

Worm, M., Moneret-Vautrin, A., Scherer, K., Lang, R., Fernandez-Rivas, M., Cardona, V., Kowalski, M. L., Jutel, M., Poziomkowska-Gesicka, I., Papadopoulos, N. G., Beyer, K., Mustakov, T., Christoff, G., Bilò, M. B., Muraro, A., Hourihane, J. O. and Grabenhenrich, L. B. (2014) ‘First European data from the network of severe allergic reactions (NORA)’, Allergy, 69(10), pp.1397-1404

Worm, M., Eckermann, O., Dölle, S., Aberer, W., Beyer, K., Hawranek, T., Hompes, S., Koehli, A., Mahler, V., Nemat, K., Niggemann, B., Pföhler, C., Rabe, U., Reissig, A., Rietschel, E., Scherer, K., Treudler, R. and Ruëff, F. (2014) ‘Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland’, Deutsches Ärzteblatt International, 111(21), pp. 367-375

Michel, S., Scherer, K., Heijnen, I. A. and Bircher, A. J. (2014) ‘Skin prick test and basophil reactivity to cetuximab in patients with IgE to alpha-gal and allergy to red meat’, Allergy, 69(3), pp. 403-405

Listyo, A., Scherer Hofmeier, K., Bandschapp, O., Erb, T., Hasler, C. C. and Bircher, A. J. (2014) ‘Severe anaphylactic shock due to ethylene oxide in a patient with myelomeningocele: successful exposure prevention and pretreatment with omalizumab’, A & A Case Reports, 2(1), pp. 3-6

Lao-Araya, M., Steveling, E. H., Scadding, G. W., Durham, S. R. and Shamji, M. H. (2014) ‘Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy’, The Journal of Allergy and Clinical Immunology, 134(5), pp. 1193-1195

Steveling, E. H., Winzeler, B. and Bircher, A. J. (2014) ‘Systemic allergic reaction to the GLP-1 receptor agonist exenatide’, The Journal of Pharmacy Technology, 30(5), pp. 182-186

Zogg, S., Dürr, S., Miedinger, D., Steveling, E. H., Maier, S. and Leuppi, J. D. (2014) ‘Differences in classification of COPD patients into risk groups A-D: a cross-sectional study’, BMC Research Notes, 7, p. 562

Dürr, S., Zogg, S., Miedinger, D., Steveling, E. H., Maier, S. and Leuppi, J. D. (2014) ‘Daily physical activity, functional capacity and quality of life in patients with COPD’, COPD, 11(6), pp. 689-696

Plessl, A., Buser, P. J., Daikeler, T., Steveling, E. H., Halter, J. and Holbro, A. (2014) ‘Alveoläre Hämorrhagie und Kokain: Ursache oder Zufall?’, Praxis, 103(22), pp. 1331-1334

Steveling, E. H., Clarenbach, C. F., Miedinger, D., Enz, C., Dürr, S., Maier, S., Sievi, N., Zogg, S., Leuppi, J. D. and Kohler, M. (2014) ‘Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease’, Respiration, 88(6), pp. 451-457

Vercoulen, Y., Bellutti Enders, F., Meerding, J., Plantinga, M., Elst, E. F., Varsani, H., van Schieveen, C., Bakker, M. H., Klein, M., Scholman, R. C., Spliet, W., Ricotti, V., Koenen, H. J. P. M., de Weger, R. A., Wedderburn, L. R., van Royen-Kerkhof, A. and Prakken, B. J. (2014) ‘Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral blood’, PLoS One, 9(8), p. e105353

Bellutti Enders, F., van Wijk, F., Scholman, R., Hofer, M., Prakken, B. J., van Royen-Kerkhof, A. and de Jager, W. (2014) ‘Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis’, Arthritis & Rheumatology, 66(8), pp. 2281-2289

2013

Reber, L. L., Marichal, T., Mukai, K., Kita, Y., Tokuoka, S. M., Roers, A., Hartmann, K., Karasuyama, H., Nadeau, K. C., Tsai, M. and Galli, S. J. (2013) ‘Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice’, The Journal of Allergy and Clinical Immunology, 132(4), pp. 881-888

Förster, A., Preussner, L. M., Seeger, J. M., Rabenhorst, A., Kashkar, H., Mrowietz, U. and Hartmann, K. (2013) ‘Dimethylfumarate induces apoptosis in human mast cells’, Experimental Dermatology, 22(11), pp. 719-724

Gotlib, J., Pardanani, A., Akin, C., Reiter, A., George, T., Hermine, O., Kluin-Nelemans, H., Hartmann, K., Sperr, W. R., Brockow, K., Schwartz, L. B., Orfao, A., Deangelo, D. J., Arock, M., Sotlar, K., Horny, H.-P., Metcalfe, D. D., Escribano, L., Verstovsek, S., Tefferi, A. and Valent, P. (2013) ‘International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis’, Blood, 121(13), pp. 2393-2401

Förster, A., Falcone, F. H., Gibbs, B. F., Preussner, L. M., Fiebig, B. S., Altunok, H., Seeger, J. M., Cerny-Reiterer, S., Rabenhorst, A., Papenfuss, K., Valent, P., Kashkar, H. and Hartmann, K. (2013) ‘Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils’, Leukemia & Lymphoma, 54(4), pp. 835-842

Hartmann, K., Wagner, N., Rabenhorst, A., Pflanz, L., Leja, S., Förster, A., Gehring, M., Kapp, A. and Raap, U. (2013) ‘Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients’, The Journal of Allergy and Clinical Immunology, 132(1), pp. 232-235

Rabenhorst, A., Christopeit, B., Leja, S., Gerbaulet, A., Kleiner, S., Förster, A., Raap, U., Wickenhauser, C. and Hartmann, K. (2013) ‘Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis’, The Journal of Allergy and Clinical Immunology, 132(5), pp. 1234-1237

Antsiferova, M., Martin, C., Huber, M., Feyerabend, T. B., Förster, A., Hartmann, K., Rodewald, H.-R., Hohl, D. and Werner, S. (2013) ‘Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis’, Journal of Immunology, 191(12), pp. 6147-6155

De Filippo, K., Dudeck, A., Hasenberg, M., Nye, E., van Rooijen, N., Hartmann, K., Gunzer, M., Roers, A. and Hogg, N. (2013) ‘Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation’, Blood, 121(24), pp. 4930-4937

Cheng, L. E., Hartmann, K., Roers, A., Krummel, M. F. and Locksley, R. M. (2013) ‘Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E’, Immunity, 38(1), pp. 166-175

Brockow, K., Garvey, L. H., Aberer, W., Atanaskovic-Markovic, M., Barbaud, A., Bilo, M. B., Bircher, A., Blanca, M., Bonadonna, B., Campi, P., Castro, E., Cernadas, J. R., Chiriac, A. M., Demoly, P., Grosber, M., Gooi, J., Lombardo, C., Mertes, P. M., Mosbech, H., Nasser, S., Pagani, M., Ring, J., Romano, A., Scherer, K., Schnyder, B., Testi, S., Torres, M., Trautmann, A. and Terreehorst, I. (2013) ‘Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper’, Allergy, 68(6), pp. 702-712

Scherer, K., Brockow, K., Aberer, W., Gooi, J. H., Demoly, P., Romano, A., Schnyder, B., Whitaker, P., Cernadas, J. S. and Bircher, A. J. (2013) ‘Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group’, Allergy, 20(3), pp. 844-852

Meyer, S. C., Rovó, A., Tsakiris, D. A., Scherer, K., Tichelli, A. and Holbro, A. (2013) ‘Severe cutaneous toxicity related to Eltrombopag’, British Journal of Haematology, 160(3), pp. 412-414

Kind, F., Scherer Hofmeier, K. and Bircher, A. J. (2013) ‘Irritant contact dermatitis from a black henna tattoo without sensitization to para-phenylendiamine’, Pediatrics, 131(6), pp. e1974-1976

Bircher, A. J., Brockow, K., Grosber, M. and Scherer Hofmeier, K. (2013) ‘Late elicitation of maculopapular exanthemas to iodinated contrast media after first exposure’, Annals of Allergy, Asthma & Immunology, 111(6), pp. 576-577

Howe, K., Clark, M.D., Torroja, C. F., Torrance, J., Berthelot, C., Muffato, M., Collins, J. E., Humphray, S., McLaren, K., Matthews, L., McLaren, S., Sealy, I., Caccamo, M., Churcher, C., Scott, C., Barrett, J. C., Koch, R., Rauch, G. J., White, S., Chow, W., Kilian, B., Quintais, L. T., Guerra-Assunção, J. A., Zhou, Y., Gu, Y., Yen, J., Vogel, J.-H., Eyre, T., Redmond, S., Banerjee, R., Chi, J., Fu, B., Langley, E., Maguire, S. F., Laird, G. K., Lloyd, D., Kenyon, E., Donaldson, S., Sehra, H., Almeida-King, J., Loveland, J., Trevanion, S., Jones, M., Quail, M., Willey, D., Hunt, A., Burton, J., Sims, S., McLay, K., Plumb, B., Davis, J., Clee, C, Oliver, K., Clark, R., Riddle, C., Elliot, D., Threadgold, G., Harden, G., Ware, D., Begum, S., Mortimore, B., Kerry, G., Heath, P., Phillimore, B., Tracey, A., Corby, N., Dunn, M., Johnson, C., Wood, J., Clark, S., Pelan, S., Griffiths, G., Smith, M., Glithero, R., Howden, P., Barker, N., Lloyd, C., Stevens, C., Harley, J., Holt, K., Panagiotidis, G., Lovell, J., Beasley, H., Henderson, C., Gordon, D., Auger, K., Wright, D., Collins, J., Raisen, C., Dyer, L., Leung, K., Robertson, L. , Ambridge, K., Leongamornlert, D., McGuire, S., Gilderthorp, R., Griffiths, C., Manthravadi, D., Nichol, S., Barker, G., Whitehead, S., Kay, M., Brown, J., Murnane, C., Gray, E., Humphries, M., Sycamore, N., Barker, D., Saunders, D., Wallis, J., Babbage, A., Hammond, S., Mashreghi-Mohammadi, M., Barr, L., Martin, S., Wray, P., Ellington, A., Matthews, N., Ellwood, M., Woodmansey, R., Clark, G., Cooper, J. D., Tromans, A., Grafham, D., Skuce, C., Pandian, R., Andrews, R., Harrison, E., Kimberley, A., Garnett, J., Fosker, N., Hall, R., Garner, P., Kelly, D., Bird, C., Palmer, S., Gehring, I., Berger, A., Dooley, C. M., Ersan-Ürün, Z., Eser, C., Geiger, H., Geisler, M., Karotki, L., Kirn, A., Konantz, J, Konantz, M., Oberländer, M., Rudolph-Geiger, S., Teucke, M., Lanz, C., Raddatz, G., Osoegawa, K., Zhu, B., Rapp, A., Widaa, S., Langford, C., Yang, F., Schuster, S. C., Carter, N. P., Harrow, J., Ning, Z., Herrero, J., Searle, S. M. J., Enright, A., Geisler, R., Plasterk, R. H. A., Lee, C., Westerfield, M., de Jong, P. J., Zon, L. I., Postlethwait, J. H., Nüsslein-Volhard, C., Hubbard, T. J. P., Roest Crollius, H., Rogers, J. and Stemple, D. L. (2013) ‘The zebrafish reference genome sequence and its relationship to the human genome’, Nature, 496(7446), pp. 498-503

Dooley, C. M., Schwarz, H., Mueller, K. P., Mongera, A., Konantz, M., Neuhauss, S. C. F., Nüsslein Volhard, C. and Geisler, R. (2013) ‘Slc45a2 and V-ATPase are regulators of melanosomal pH homeostasis in zebrafish, providing a mechanism for human pigment evolution and disease’, Pigment Cell & Melanoma Research, 26(2), pp. 205-217

Konantz, M., André, M. C., Ebinger, M., Grauer, M., Wang, H., Grzywna, S., Rothfuss, O. C., Lehle, S., Kustikova, O. S., Salih, H. R., Handgretinger, R., Fend, F., Baum, C., Kanz, L., Quintanilla-Martinez, L., Schulze-Osthoff, K., Essmann, F. and Lengerke, C. (2013) ‘EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia’, Leukemia, 27(1), pp. 56-65

Viganò, S., Bellutti Enders, F., Miconnet, I., Cellerai, C., Savoye, A.-L., Rozot, V., Perreau, M., Faouzi, M., Ohmiti, K., Cavassini, M., Bart, P.-A., Pantaleo, G. and Harari, A. (2013) ‘Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cell’, PLoS Pathogens, 9(7), p. e1003423

Perreau, M., Rozot, V., Welles, H. C., Belluti-Enders, F., Vigano, S., Maillard, M., Dorta, G., Mazza-Stalder, J., Bart, P.-A., Roger, T., Calandra, T., Nicod, L. and Harari, A. (2013) ‘Lack of mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease’, European Journal of Immunology, 43(4), pp. 939-948

2012

Sharma, N., Kumar, V., Everingham, S., Mali, R. S., Kapur, R., Zeng, L.-F., Zhang, Z.-Y., Feng, G.-S., Hartmann, K., Roers, A. and Craig, A. W. B. (2012) ‘SH2 domain-containing phosphatase 2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice’, Molecular and Cellular Biology, 32(14), pp. 2653-2663

Rabenhorst, A., Schlaak, M., Heukamp, L. C., Förster, A., Theurich, S., von Bergwelt-Baildon, M., Büttner, R., Kurschat, P., Mauch, C., Roers, A. and Hartmann, K. (2012) ‘Mast cells play a protumorigenic role in primary cutaneous lymphoma’, Blood, 120(10), pp. 2042-2054

Yagil, Z., Hadad Erlich, T., Ofir-Birin, Y., Tshori, S., Kay, G., Yekhtin, Z., Fisher, D. E., Cheng, C., Wong, W. S. F., Hartmann, K., Razin, E. and Nechushtan, H. (2012) ‘Transcription factor E3, a major regulator of mast cell-mediated allergic response’, The Journal of Allergy and Clinical Immunology, 129(5), pp. 1357-1366

Bork, K., Maurer, M., Bas, M., Hartmann, K., Biedermann, T., Kreuz, W., Aygören-Pürsün, E., Martinez-Saguer, I., Ott, H. and Wedi, B. (2012) ‘Hereditäres Angioödem durch C1-Inhibitor-Mangel. Leitlinie der Deutschen Gesellschaft für Angioödeme, der Deutschen Gesellschaft für Innere Medizin, der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, der Deutschen Gesellschaft für Allergologie und Klinische Immunologie, der Deutschen Gesellschaft für Kinder- und Jugendmedizin, der Deutschen Dermatologischen Gesellschaft und der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin’, Allergo Journal, 21, pp. 109-118

Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., Nedoszytko, B., Orfao, A., Schwartz, L. B., Sotlar, K., Sperr, W. R., Triggiani, M., Valenta, R., Horny, H.-P. and Metcalfe, D. D. (2012) ‘Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal’, International Archives of Allergy and Immunology, 157(3), pp. 215-225

Wagner, N., Jappe, U., Podda, M. and Hartmann, K. (2012) ‘Anaphylaxien auf rotes Fleisch: Galactose-alpha-1,3-galactose (alpha-Gal) - ein interessantes Allergen’, Allergologie, 35(11), pp. 559-562

Valent, P., Arock, M., Bonadonna, P., Brockow, K., Broesby-Olsen, S., Escribano, L., Gleixner, K. V., Grattan, C., Hadzijusufovic, E., Hägglund, H., Hermine, O., Horny, H.-P., Kluin-Nelemans, H. C., Maurer, M., Niedoszytko, M., Nedoszytko, B., Nilsson, G., Oude-Elberink, H. N. G., Orfao, A., Radia, D., Reiter, A., Siebenhaar, F., Sotlar, K., Sperr, W. R., Triggiani, M., VanDoormaal, J. J., Várkonyi, J., Yavuz, S. and Hartmann, K. (2012) ‘European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives’, Wiener klinische Wochenschrift, 124(23-24), pp. 807-814

Scherer Hofmeier, K., Bircher, A., Tamm, M. and Miedinger, D. (2012) ‘Berufliche Rhinitis und Asthma’, Therapeutische Umschau, 69(4), pp. 261-267

Bircher, A. J. and Scherer Hofmeier, K. (2012) ‘Drug hypersensitivity reactions during hematopoietic stem cell transplantation’, Current Problems in Dermatology, 43, pp. 150-164

Bircher, A. J. and Scherer Hofmeier, K. (2012) ‘Drug hypersensitivity reactions: inconsistency in the use of the classification of immediate and nonimmediate reactions’, Journal of Allergy and Clinical Immunology, 129(1), pp. 263-264

Grabenhenrich, L., Hompes, S., Gough, H., Ruëff, F., Scherer, K., Pföhler, C., Treudler, R., Mahler, V., Hawranek, T., Nemat, K., Koehli, A., Keil, T. and Worm, M. (2012) ‘Implementation of anaphylaxis management guidelines: a register-based study’, PLOS One, 7(5), p. 35778

Brož, P., Harr, T., Hecking, C., Grize, L., Scherer, K., Jaeger, K. A. and Bircher, A. J. (2012) ‘Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin’, Allergy, 67(5), pp. 647-652

Worm, M., Edenharter, G., Ruëff, F., Scherer, K., Pföhler, C., Mahler, V., Treudler, R., Lang, R., Nemat, K., Koehli, A., Niggemann, B. and Hompes, S. (2012) ‘Symptom profile and risk factors of anaphylaxis in Central Europe’, Allergy, 67(5) pp. 691-698

Bonadonna, P., Lombardo, C., Bortolami, O., Bircher, A., Scherer, K., Barbaud, A., Passalacqua, G. and Pagani, M. (2012) ‘Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test’, Journal of Allergy and Clinical Immunology, 130(2), pp. 547-549

Scherer, K., Schindler, C., Arnold, A., Bach, S. and Bircher, A. J. (2012) ‘Analysis of an unusual cluster of systemic reactions to subcutaneous specific immunotherapy with respiratory allergens in one allergy center’, International Archives of Allergy and Immunology, 157(3), pp. 318-320

Kind, F., Scherer, K. and Bircher, A. J. (2012) ‘Contact dermatitis to para-phenylenediamine in hair dye following sensitization to black henna tattoos - an ongoing problem’, Journal der Deutschen Dermatologischen Gesellschaft, 10(8), pp. 572-578

Bircher, A., Friederich, N. F., Seelig, W. and Scherer, K. (2012) ‘Allergic complications from orthopaedic joint implants: the role of delayed hypersensitivity to benzoyl peroxide in bone cement’, Contact Dermatitis, 66(1), pp. 20-26

McKinney-Freeman, S., Cahan, P., Li, H., Lacadie, S. A., Huang, H.-T., Curran, M., Loewer, S., Naveiras, O., Kathrein, K. L., Konantz, M., Langdon, E. M., Lengerke, C., Zon, L. I., Collins, J. J. and Daley, G. Q. (2012) ‘The transcriptional landscape of hematopoietic stem cell ontogeny’, Cell Stem Cell, 11(5), pp. 701-714

Konantz, M., Balci, T. B., Hartwig, U. F., Dellaire, G., André, M. C., Berman, J. N. and Lengerke, C. (2012) ‘Zebrafish xenografts as a tool for in vivo studies on human cancer’, Annals of the New York Academy of Sciences, 1266, pp. 124-137

Meyer, S. C., Steveling, E. H., D’Souza, M. and Hug, B. L. (2012) ‘Schmerzhafte Parese und Hautausschlag’, Schweizerische medizinische Wochenschrift, 12(36), pp. 694-695

Harari, A., Rozot, V., Cavassini, M., Bellutti Enders, F., Vigano, S., Tapia, G., Castro, E., Burnet, S., Lange, J., Moog, C., Garin, D., Costagliola, D., Autran, B., Pantaleo, G. and Bart, P.-A. (2012) ‘NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients’, European Journal of Immunology, 42(11), pp. 3038-3048

2011

Wagner, N. and Hartmann, K. (2011) ‘Mastozytose - Diagnostisches und therapeutisches Management’, Aktuelle Dermatologie, 37(11), pp. 419-427

Gerbaulet, A., Wickenhauser, C., Scholten, J., Peschke, K., Drube, S., Horny, H.-P., Kamradt, T., Naumann, R., Müller, W., Krieg, T., Waskow, C., Hartmann, K. and Roers, A. (2011) ‘Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit’, Blood, 117(6), pp. 2012-2021

von Bartenwerffer, W., Has, C., Arin, M. J., Tantcheva-Poór, I., Kreuter, A., Kremer, K., Arshah, T., Hoffmann, M., Eming, S. A., Kohlhase, J., Krieg, T., Bruckner-Tuderman, L. and Hartmann, K. (2011) ‘Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations’, European Journal of Dermatology, 21(2), pp. 170-172

Zuberbier, T., Aberer, W., Brockow, K., Grabbe, J., Hamelmann, E., Hartmann, K., Jakob, T., Merk, H., Ollert, M., Ruëff, F., Schmid-Grendelmeier, P., Staubach, P., Voigtmann, I., Wedi, B. and Maurer, M. (2011) ‘S3-Leitlinie Urtikaria: Teil 1: Klassifikation und Diagnostik der Urtikaria - deutschsprachige Version der internationalen S3-Leitlinie. Teil 2: Therapie der Urtikaria - deutschsprachige Version der internationalen S3-Leitlinie. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie und der Deutschen Dermatologischen Gesellschaft unter Beteiligung der Österreichischen Gesellschaft für Allergologie und Immunologie, der Schweizer Gesellschaft für Allergologie und Immunologie, des Ärzteverbandes Deutscher Allergologen und der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin’, Allergo Journal, 20, pp. 249-276

Dudeck, A., Dudeck, J., Scholten, J., Petzold, A., Surianarayanan, S., Köhler, A., Peschke, K., Vöhringer, D., Waskow, C., Krieg, T., Müller, W., Waisman, A., Hartmann, K., Gunzer, M. and Roers, A. (2011) ‘Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens’, Immunity, 34(6), pp. 973-984

Heijnen, I. A. F. M., Scherer Hofmeier, K., Link, S. and Bircher, A. J. (2011) ‘IgE-mediated allergy to recombinant human growth hormone (somatotropin)’, Allergologie, 34(2), pp. 87-88

Spoerl, D., Scherer, K. and Tyndall, A. (2011) ‘Aspects of allergy in rheumatology’, Clinical and Experimental Rheumatology, 29(3), pp. 560-566

Hompes, S., Köhli, A., Nemat, K., Scherer, K., Lange, L., Rueff, F., Rietschel, E., Reese, T., Szepfalusi, Z., Schwerk, N., Beyer, K., Hawranek, T., Niggemann, B. and Worm, M. (2011) ‘Provoking allergens and treatment of anaphylaxis in children and adolescents - data from the anaphylaxis registry of German-speaking countries’, Pediatric Allergy and Immunology, 22(6), pp. 568-574

Spoerl, D., Bircher, A. J. and Scherer, K. (2011) ‘Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom’, Journal of Investigational Allergy and Clinical Immunology, 21(1), pp. 22-27

Duchini, G., Bäumler, W., Bircher, A. J. and Scherer, K. (2011) ‘Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light’, Photodermatology, Photoimmunology & Photomedicine, 27(6), pp.336-337

Lengerke, C., Wingert, R., Beeretz, M., Grauer, M., Schmidt, A. G., Konantz, M., Daley, G. Q. and Davidson, A. J. (2011) ‘Interactions between Cdx genes and retinoic acid modulate early cardiogenesis’, Developmental Biology, 354(1), pp. 134-142

Harari, A., Rozot, V., Bellutti Enders, F., Perreau, M., Mazza Stalder, J., Nicod, L. P., Cavassini, M., Calandra, T., Lazor Blanchet, C., Jaton, K., Faouzi, M., Day, C. L., Hanekom, W. A., Bart, P.-A. and Pantaleo, G. (2011) ‘Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease’, Nature Medicine, 17(3), pp. 372-376

2010

Valent, P., Arock, M., Akin, C., Sperr, W. R., Reiter, A., Sotlar, K., Hartmann, K., George, T. I., Brockow, K., Kluin-Nelemans, H. C., Gotlib, J., Metcalfe, D. D. and Horny, H.-P. (2010) ‘The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)’, Blood, 116(5), pp. 850-851

Hartmann, K., Siebenhaar, F., Belloni, B., Brockow, K., Eben, R., Hartmann, B., Ruëff, F., Schoepke, N., Staubach, P., Weber, A. and Maurer, M. (2010) ‘Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial’, The British Journal of Dermatology, 162(1), pp. 185-190

Amon, U., Hartmann, K., Horny, H.-P. and Nowak, A. (2010) ‘Mastocytosis - an update’, Journal der Deutschen Dermatologischen Gesellschaft, 8(9), pp. 695-711

Löhrer, R., Neumann-Acikel, A., Eming, R., Hartmann, K., Rasokat, H., Krieg, T., Happle, R. and Eming, S. (2010) ‘A case of linear porokeratosis superimposed on disseminated superficial actinic porokeratosis’, Case Reports in Dermatology, 2(2), pp. 130-134

Drube, S., Heink, S., Walter, S., Löhn, T., Grusser, M., Gerbaulet, A., Berod, L., Schons, J., Dudeck, A., Freitag, J., Grotha, S., Reich, D., Rudeschko, O., Norgauer, J., Hartmann, K., Roers, A. and Kamradt, T. (2010) ‘The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells’, Blood, 115(19), pp. 3899-3906

Bircher, A. J. and Scherer, K. (2010) ‘Delayed cutaneous manifestations of drug hypersensitivity’, Medical Clinics of North America, 94(4), pp. 711-725

Scherer, K., Spoerl, D. and Bircher, A. J. (2010) ‘Adverse drug reactions to biologics’, Journal der Deutschen Dermatologischen Gesellschaft, 8(6), pp. 411-426

Scherer, K. and Bircher, A. J. (2010) ‘Danger signs in drug hypersensitivity’, Medical Clinics of North America, 94(4), pp. 681-689

Spoerl, D., Scherer, K. and Bircher, A. J. (2010) ‘Contact urticaria with systemic symptoms due to hexylene glycol in a topical corticosteroid: case report and review of hypersensitivity to glycols’, Dermatology, 220(3), pp. 238-242

Miedinger, D., Mosimann, N., Meier, R., Karli, C., Florek, P., Frey, F., Scherer, K., Surber, C., Villiger, B., Michel, F. and Leuppi, J. D. (2010) ‘Asthma tests in the assessment of military conscripts’, Clinical and Experimental Allergy, 40(2), pp. 224-231

Scherer, K., Harr, T., Bach, S. and Bircher, A. J. (2010) ‘The role of iodine in hypersensitivity reactions to radio contrast media’, Clinical and Experimental Allergy, 40(3), pp. 468-475

Kind, F., Scherer, K. and Bircher, A. J. (2010) ‘Allergic contact stomatitis to cinnamon in chewing gum mistaken as facial angioedema’, Allergy, 65(2), pp.276-277

Cellerai, C., Perreau, M., Rozot, V., Bellutti Enders, F., Pantaleo, G. and Harari, A. (2010) ‘Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression’, Journal of Virology, 84(8), pp. 3868-3878

2009

Hartmann, K., Biedermann, T., Brockow, K., Grabbe, J., Horny, H.-P., Lippert, U., Maurer, M., Raithel, M., Rietschel, E., Ruëff, F. and Sotlar, K. (2009) ‘Mastozytose. Leitlinie der Deutschen Dermatologischen Gesellschaft und der Deutschen Gesellschaft für Allergologie und Klinische Immunologie’, Allergo Journal, 18, pp. 196-207

Hartmann, K. (2009) ‘Treatment of allergic angioedema’, in Kojda, G., Hoffmann, T. K., and Bas, M. (eds). Stuttgart: Georg Thieme Verlag (Angioedema Congress Book), pp. 16-19

Wasiuk, A., de Vries, V. C., Hartmann, K., Roers, A. and Noelle, R. J. (2009) ‘Mast cells as regulators of adaptive immunity to tumours’, Clinical and Experimental Immunology, 155(2), pp. 140-146

Scherer, K., Bircher, A. J. and Heijnen, I. A. (2009) ‘Diagnosis of stinging insect allergy: utility of cellular in-vitro tests’, Current Opinion in Allergy and Clinical Immunology, 9(4), pp. 343-350

Scherer, K. and Bircher, A. (2009) ‘Unerwünschte Arzneimittelreaktionen an der Haut’, Der Internist, 50(2), pp. 171-178

Taegtmeyer, A. B., Steurer-Stey, C., Spertini, F., Bircher, A., Helbling, A., Miedinger, D., Schafroth, S., Scherer, K. and Leuppi, J. D. (2009) ‘Allergic rhinitis in patients with asthma: the Swiss LARA (Link Allergic Rhinitis in Asthma) survey’, Current Medical Research and Opinion, 25(5), pp.1073-1080

Bircher, A. J., Schmidli, F., Strub, C., Müller, B. and Scherer, K. (2009) ‘Systemic allergic dermatitis reaction to nickel released from an eyelet in an intravenous catheter’, Contact Dermatitis, 61(3), pp. 180-182

Steveling, E. H., Atta, J., Stowasser, M. and Reichenberger, F. (2009) ‘Exertional dyspnoea and leukocytosis’, Der Pneumologe, 6(3), pp. 172-175

Harari, A., Bellutti Enders, F., Cellerai, C., Bart, P.-A. and Pantaleo, G. (2009) ‘Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure’, Journal of Virology, 83(7), pp. 2862-2871

2008

Lange, L., Rietschel, E., Hunzelmann, N. and Hartmann, K. (2008) ‘Elevated levels of tryptase in children with nummular eczema’, Allergy, 63(7), pp. 947-949

Horny, H.-P., Sotlar, K., Valent, P. and Hartmann, K. (2008) ‘Mastocytosis: a disease of the hematopoietic stem cell’, Deutsches Ärzteblatt International, 105(40), pp. 686-692

Schuster, J., Tantcheva-Poor, I., Wickenhauser, C., Chemnitz, J.-M., Hunzelmann, N., Krieg, T. and Hartmann, K. (2008) ‘African tick bite fever - papulovesicular exanthem with fever after staying in South Africa’, Journal der Deutschen Dermatologischen Gesellschaft, 6(5), pp. 379-381

Saggar, S., Chernoff, K. A., Lodha, S., Horev, L., Kohl, S., Honjo, R. S., Brandt, H. R. C., Hartmann, K. and Celebi, J. T. (2008) ‘CYLD mutations in familial skin appendage tumours’, Journal of Medical Genetics, 45(5), pp. 298-302

Tantcheva-Poor, I., Hartmann, K. and Mauch, C. (2008) ‘Linear livid papules on the leg in a 4-year-old child’, Pediatric Dermatology, 25(6), pp. 633-634

Scholten, J., Hartmann, K., Gerbaulet, A., Krieg, T., Müller, W., Testa, G. and Roers, A. (2008) ‘Mast cell-specific Cre/loxP-mediated recombination in vivo’, Transgenic Research, 17(2), pp. 307-315

Scherer, K., Ballmer-Weber, B. K. and Bircher, A. J. (2008) ‘Highlights in nonhymenoptera anaphylaxis’, Current Opinion in Allergy and Clinical Immunology, 8(4), pp. 348-353

Scherer, K., Tsakiris, D. A. and Bircher, A. J. (2008) ‘Hypersensitivity reactions to anticoagulant drugs’, Current Pharmaceutical Design, 14(27), pp. 2863-2873

Egger, C., Focke, M., Bircher, A. J., Scherer, K., Mothes-Luksch, N., Horak, F. and Valenta, R. (2008) ‘The allergen profile of beech and oak pollen’, Clinical and Experimental Allergy, 38(10), pp. 1688-1696

Waner, M., Kastenbaum, J. and Scherer, K. (2008) ‘Hemangiomas of the nose: surgical management using a modified subunit approach’, Archives of Facial Plastic Surgery, 10(5), pp. 329-334

Scherer, K., Weber, J. M., Jermann, T. M., Krautheim, A., Tas, E., Ueberschlag, E. V., Cammarata, M. and Bircher, A. J. (2008) ‘Cellular in vitro assays in the diagnosis of hymenoptera venom allergy’, International Archives of Allergy and Immunology, 146(2), pp. 122-132

2007

Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin-Nelemans, H. C., Hamdy, N. A. T., Lortholary, O., Robyn, J., van Doormaal, J., Sotlar, K., Hauswirth, A. W., Arock, M., Hermine, O., Hellmann, A., Triggiani, M., Niedoszytko, M., Schwartz, L. B., Orfao, A., Horny, H.-P. and Metcalfe, D. D. (2007) ‘Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria’, European Journal of Clinical Investigation, 37(6), pp. 435-453

Babilas, P., Scherer, K., Landthaler, M., Ehrenstein, B. and Szeimies, R. M. (2007) ‘Nokardioseinfektion einer Gefäßendoprothese’, Der Hautarzt, 58(4), pp. 335-337

Scherer, K., Grize, L., Schindler, C., Surber, C. and Bircher, A. J. (2007) ‘Reaction pattern to histamine and codeine in a human intradermal skin test model’, Clinical and Experimental Allergy, 37(1), pp. 39-46

Scherer, K. and Waner, M. (2007) ‘Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits’, Lasers in Medical Science, 22(2), pp. 119-126

Geisler, R., Rauch, G.-J., Geiger-Rudolph, S., Albrecht, A., van Bebber, F., Berger, A., Busch-Nentwich, E., Dahm, R., Dekens, M. P. S., Dooley, C., Elli, A. F., Gehring, I., Geiger, H., Geisler, M., Glaser, S., Holley, S., Huber, M., Kerr, A., Kirn, A., Knirsch, M., Konantz, M., Küchler, A. M., Maderspacher, F., Neuhauss, S. C., Nicolson, T., Ober, E. A., Praeg, E., Ray, R., Rentzsch, B., Rick, J. M., Rief, E., Schauerte, H. E., Schepp, C. P., Schönberger, U., Schonthaler, H. B., Seiler, C., Söllner, C., Wehner, A., Weiler, C. and Nüsslein-Volhard, C. (2007) ‘Large-scale mapping of mutations affecting zebrafish development’, BMC Genomics, 8, p. 11

Harari, A., Cellerai, C., Bellutti Enders, F., Köstler, J., Codarri, L., Tapia, G., Boyman, O., Castro, E., Gaudieri, S., James, I., John, M., Wagner, R., Mallal, S. and Pantaleo, G. (2007) ‘Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype’, Proceedings of the National Academy of Sciences of the United States of America, 104(41), pp. 16233-16238

2006

Gerbaulet, A., Hartmann, K. and Mekori, Y. A. (2006) ‘Mast cell apoptosis’, Methods in Molecular Biology, 315, pp. 407-423

Stratis, A., Pasparakis, M., Rupec, R. A., Markur, D., Hartmann, K., Scharffetter-Kochanek, K., Peters, T., van Rooijen, N., Krieg, T. and Haase, I. (2006) ‘Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation’, The Journal of Clinical Investigation, 116(8), pp. 2094-2104

Scherer, K., Bircher, A. J. and Figueiredo, V. (2006) ‘Blue dyes in medicine--a confusing terminology’, Contact Dermatitis, 54(4), pp. 231-232

Scherer, K., Studer, W., Figueiredo, V. and Bircher, A. J. (2006) ‘Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes’, Annals of Allergy, Asthma & Immunology, 96(3), pp. 497-500

Witman, P. M., Wagner, A. M., Scherer, K., Waner, M. and Frieden, I. J. (2006) ‘Complications following pulsed dye laser treatment of superficial hemangiomas’, Lasers in Surgery and Medicine, 38(2), pp. 116-123

Harr, T., Scherer, K., Tsakiris, D. A. and Bircher, A. J. (2006) ‘Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux’, Allergy, 61(6), pp. 787-788

Buergin, S., Scherer, K., Häusermann, P. and Bircher, A. J. (2006) ‘Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance’, International Archives of Allergy and Immunology, 140(1), pp. 79-84

Reichenberger, F., Voswinckel, R., Steveling, E. H., Enke, B., Kreckel, A., Olschewski, H., Grimminger, F., Seeger, W. and Ghofrani, H. A. (2006) ‘Sildenafil treatment for portopulmonary hypertension’, The European Respiratory Journal, 28(3), pp. 563-567

2005

Hartmann, K., Wardelmann, E., Ma, Y., Merkelbach-Bruse, S., Preussner, L. M., Woolery, C., Baldus, S. E., Heinicke, T., Thiele, J., Buettner, R. and Longley, B. J. (2005) ‘Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis’, Gastroenterology, 129(3), pp. 1042-1046

Scherer, K. and Bircher, A. J. (2005) ‘Hypersensitivity reactions to fluoroquinolones’, Current Allergy and Asthma Reports, 5(1), pp.15-21

Hausermann, P., Scherer, K., Weber, M. and Bircher, A. J. (2005) ‘Ciprofloxacin-induced acute generalized exanthematous pustulosis mimicking bullous drug eruption confirmed by a positive patch test’, Dermatology, 211(3), pp. 277-280

2004

Hartmann, K. and Hunzelmann, N. (2004) ‘Allergic contact dermatitis from cinnamon as an odour-neutralizing agent in shoe insoles’, Contact Dermatitis, 50(4), pp. 253-254

Valent, P., Arock, M., Bischoff, S. C., Bühring, H.-J., Brockow, K., Escribano, L., Födinger, M., Grabbe, J., Hartmann, K., Henz, B. M., Horny, H.-P., Kluin-Nelemans, H. C., Lima, M., Marone, G., Orfao, A., Parwaresch, R. M., Sillaber, C., Sotlar, K., Sperr, W. R., Triggiani, M., Van Doormaal, J. J., Wolff, K. and Zuberbier, T. (2004) ‘The European Competence Network on Mastocytosis (ECNM)’, Wiener klinische Wochenschrift, 116(19-20), pp. 647-651

Baldus, S. E., Zirbes, T. K., Thiele, J., Eming, S. A., Henz, B. M. and Hartmann, K. (2004) ‘Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis’, Haematologica, 89(12), pp. 1525-1527

Hartmann, K. (2004) ‘Urticaria. Classification and diagnosis’, Der Hautarzt, 55(4), pp. 340-343

Scherer, K. and Bircher, A. J. (2004) ‘Wenn’s eng wird… oder das Angioödem des Oropharynx’, Therapeutische Umschau, 61(5), pp. 341-347

Scherer, K., Abels, C., Bäumler, W., Ackermann, G. and Szeimies, R. M. (2004) ‘Structure-activity relationships of three differently substituted 2,7,12,17-tetrakis-(beta-methoxyethyl) porphycene derivatives in vitro’, Archives of Dermatological Research, 295(12), pp. 535-541

2003

Hartmann, K. (2003) ‘Kindliche Mastozytosen’, Kinder- und Jugendmedizin, 3, pp. 111-116

Guhl, S., Hartmann, K., Tapkenhinrichs, S., Smorodchenko, A., Grützkau, A., Henz, B. M. and Zuberbier, T. (2003) ‘Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells’, The Journal of Investigative Dermatology, 121(4), pp. 837-844

Hartmann, K., Artuc, M., Baldus, S. E., Zirbes, T. K., Hermes, B., Thiele, J., Mekori, Y. A. and Henz, B. M. (2003) ‘Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis’, The American Journal of Pathology, 163(3), pp. 819-826

Hartmann, K., Hermes, B., Rappersberger, K., Sepp, N., Mekori, Y. A. and Henz, B. M. (2003) ‘Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis’, The British Journal of Dermatology, 149(3), pp. 554-559

Zuberbier, T., Aberer, W., Grabbe, J., Hartmann, K., Merk, H., Ollert, M., Ruëff, F., Wedi, B. and Wenning, J. (2003) ‘Diagnostik und Therapie der Urtikaria. Leitlinie der Deutschen Gesellschaft und des Berufsverbandes Deutscher Dermatologen’, Journal der Deutschen Dermatologischen Gesellschaft, 1, pp. 655-664

Waner, M., North, P. E., Scherer, K. A., Frieden, I. J., Waner, A. and Mihm, M. C. Jr. (2003) ‘The nonrandom distribution of facial hemangiomas’, Archives of Dermatology, 139(7), pp. 869-875

Farkas, B., Hantschel, M., Magyarlaki, M., Becker, B., Scherer, K., Landthaler, M., Pfister, K., Gehrmann, M., Gross, C., Mackensen, A. and Multhoff, G. (2003) ‘Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma’, Melanoma Research, 13(2), pp. 147-152

Lorenz, S., Scherer, K., Wimmershoff, M. B., Landthaler, M. and Hohenleutner, U. (2003) ‘Variable pulse frequency-doubled Nd:YAG laser versus flashlamp-pumped pulsed dye laser in the treatment of port wine stains’, Acta Dermato-Venereologica, 83(3), pp. 210-213

2002

Hartmann, K. and Henz, B. M. (2002) ‘Cutaneous mastocytosis - clinical heterogeneity’, International Archives of Allergy and Immunology, 127(2), pp. 143-146

Hartmann, K. and Henz, B. M. (2002) ‘Classification of cutaneous mastocytosis: a modified consensus proposal’, Leukemia Research, 26(5), pp. 483-484

Piecha, D., Hartmann, K., Kobbe, B., Haase, I., Mauch, C., Krieg, T. and Paulsson, M. (2002) ‘Expression of matrilin-2 in human skin’, The Journal of Investigative Dermatology, 119(1), pp. 38-43

Scherer, K., Hintz, C. and Burgdorf, W. (2002) ‘Tumorassoziierte Genodermatosen', Der Hautarzt, 53(1), pp. 55-77

Bäumler, W., Scherer, K., Abels, C., Neff, S., Landthaler, M. and Szeimies, R. M. (2002) ‘The effect of different spot sizes on the efficacy of hair removal using a long-pulsed diode laser’, Dermatologic Surgery, 28(2), pp. 118-121

Ackermann, G., Hartmann, M., Scherer, K., Lang, E. W., Hohenleutner, U., Landthaler, M. and Bäumler, W. (2002) ‘Correlations between light penetration into skin and the therapeutic outcome following laser therapy of port-wine stains’, Lasers in Medical Science, 17(2), pp. 70-78

2001

Hartmann, K., Hani, N., Hinrichs, R., Hunzelmann, N. and Scharffetter-Kochanek, K. (2001) ‘Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria’, Acta Dermato-Venereologica, 81(1), p. 71

Mekori, Y. A., Gilfillan, A. M., Akin, C., Hartmann, K. and Metcalfe, D. D. (2001) ‘Human mast cell apoptosis is regulated through Bcl-2 and Bcl-xL’, Journal of Clinical Immunology, 21(3), pp. 171-174

Henz, B. M., Hartmann, K. and Hermes, B. (2001) ‘Therapie der physikalischen Urtikaria: Antihistaminika und Alternativen’, Allergologie, 24(2), pp. 56-65

Hartmann, K., Bruns, S. B. and Henz, B. M. (2001) ‘Mastocytosis: review of clinical and experimental aspects’, The Journal of Investigative Dermatology. Symposium Proceedings, 6(2), pp. 143-147

Hartmann, K. and Henz, B. M. (2001) ‘Mastocytosis: recent advances in defining the disease’, The British Journal of Dermatology, 144(4), pp. 682-695

Eming, S. A., Peters, T., Hartmann, K., Scharffetter-Kochanek, K. and Mahrle, G. (2001) ‘Lichenoid chronic graft-versus-host disease-like acrodermatitis induced by hydroxyurea’, Journal of the American Academy of Dermatology, 45(2), pp. 321-323

Hermes, B., Welker, P., Feldmann-Böddeker, I., Krüger-Krasagakis, S., Hartmann, K., Zuberbier, T. and Henz, B. M. (2001) ‘Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars’, The Journal of Investigative Dermatology, 116(3), pp. 387-393

Yamamoto, T., Eckes, B., Hartmann, K. and Krieg, T. (2001) ‘Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis’, Journal of Dermatological Science, 26(2), pp. 133-139

Yamamoto, T., Hartmann, K., Eckes, B. and Krieg, T. (2001) ‘Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis’, Journal of Dermatological Science, 26(2), pp. 106-111

Scherer, K., Lorenz, S., Wimmershoff, M., Landthaler, M. and Hohenleutner, U. (2001) ‘Both the flashlamp-pumped dye laser and the long-pulsed tunable dye laser can improve results in port-wine stain therapy’, British Journal of Dermatology, 145(1), pp.79-84

Wimmershoff, M. B., Scherer, K., Bäumler, W., Hohenleutner, U. and Landthaler, M. (2001) ‘Behandlung von therapieresistenten Verrucae vulgares mit dem lang-gepulsten Farbstofflaser’, Der Hautarzt, 52(8), pp. 701-704

2000

Hartmann, K. and Metcalfe, D. D. (2000) ‘Pediatric mastocytosis’, Hematology/Oncology Clinics of North America, 14(3), pp. 625-640

Hartmann, K. and Metcalfe, D. D. (2000) ‘Regulation and dysregulation of mast cell survival and apoptosis’, in Marone, G., Lichtenstein, L. M., and Galli, S. J. (eds). San Diego: Academic Press (Mast Cells and Basophils), pp. 51-60

Hani, N., Hartmann, K., Casper, C., Peters, T., Schneider, L. A., Hunzelmann, N. and Scharffetter-Kochanek, K. (2000) ‘Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast’, Acta Dermato-Venereologica, 80(3), p. 229

Yamamoto, T., Hartmann, K., Eckes, B. and Krieg, T. (2000) ‘Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/c-kit’, Immunology, 99(3), pp. 435-439

Yamamoto, T., Eckes, B., Mauch, C., Hartmann, K. and Krieg, T. (2000) ‘Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop’, Journal of Immunology, 164(12), pp. 6174-6179

Hartmann, K. (2000) ‘Biogene Amine’, Aktuelle Dermatologie, 26, pp. 23-25

Wimmershoff, M. B., Scherer, K., Lorenz, S., Landthaler, M. and Hohenleutner, U. (2000) ‘Hair removal using a 5-msec long-pulsed ruby laser’, Dermatologic Surgery, 26(3), pp. 205-210

Scherer, K., Szeimies, R. M. and Landthaler, M. (2000) ‘Ektopes Parotisgewebe – Eine ungewöhnliche Differentialdiagnose zervikaler zystischer Tumoren’, Der Hautarzt, 51(11), pp. 865-868

1999

Mekori, Y. A., Hartmann, K. and Metcalfe, D. D. (1999) ‘Mast cell apoptosis and its regulation’, in Razin, E. and Rivera, J. (eds). New York: Springer (Signal Transduction in Mast Cells and Basophils), pp. 85-94

Hartmann, K. and Even, G. (1999) ‘Acanthosis nigricans, Adipositas, Insulinresistenz, Hypothyreose und atopische Dermatitis bei einem Patienten. Bedingtes oder zufälliges Zusammentreffen?’, Zeitschrift für Hautkrankheiten, 74, pp. 694-696

1998

Lippert, U., Artuc, M., Grützkau, A., Möller, A., Kenderessy-Szabo, A., Schadendorf, D., Norgauer, J., Hartmann, K., Schweitzer-Stenner, R., Zuberbier, T., Henz, B. M. and Krüger-Krasagakes, S. (1998) ‘Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells’, Journal of Immunology, 161(5), pp. 2600-2608

Wagelie-Steffen, A. L., Hartmann, K., Vliagoftis, H. and Metcalfe, D. D. (1998) ‘Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells’, Immunology, 94(4), pp. 569-574

Scherer, K., Müller, T., Stolz, W., Aebert, H. and Schunkert, H. (1998) ‘Ein Fall von Carney-Komplex’, Deutsche Medizinische Wochenschrift, 123(33), pp. 972-976

1997

Hartmann, K., Henz, B. M., Krüger-Krasagakes, S., Köhl, J., Burger, R., Guhl, S., Haase, I., Lippert, U. and Zuberbier, T. (1997) ‘C3a and C5a stimulate chemotaxis of human mast cells’, Blood, 89(8), pp. 2863-2870

Hartmann, K., Wagelie-Steffen, A. L., von Stebut, E. and Metcalfe, D. D. (1997) ‘Fas (CD95, APO-1) antigen expression and function in murine mast cells’, Journal of Immunology, 159(8), pp. 4006-4014

Zuberbier, T., Schadendorf, D., Haas, N., Hartmann, K. and Henz, B. M. (1997) ‘Enhanced P-selectin expression in chronic and dermographic urticaria’, International Archives of Allergy and Immunology, 114(1), pp. 86-89

1996

Zuberbier, T., Schwarz, S., Hartmann, K., Pfrommer, C. and Czarnetzki, B. M. (1996) ‘Histamine releasability of basophils and skin mast cells in chronic urticaria’, Allergy, 51(1), pp. 24-28

Zimmer, M., Fink, T., Fischer, L., Hauser, W., Scherer, K., Lichter, P. and Walter, U. (1996) ‘Cloning of the VASP (vasodilator-stimulated phosphoprotein) genes in human and mouse: structure, sequence, and chromosomal localization’, Genomics, 36(2), pp. 227-233

1995

Zuberbier, T., Chantraine-Hess, S., Hartmann, K. and Czarnetzki, B. M. (1995) ‘Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study’, Acta Dermato-Venereologica, 75(6), pp. 484-487

Zuberbier, T., Pfrommer, C., Beinhölzl, J., Hartmann, K., Ricklinkat, J. and Czarnetzki, B. M. (1995) ‘Gangliosides enhance IgE receptor-dependent histamine and LTC4 release from human mast cells’, Biochimica et Biophysica Acta, 1269(1), pp. 79-84

Hartmann, K., Beiglböck, F., Czarnetzki, B. M. and Zuberbier, T. (1995) ‘Effect of CC chemokines on mediator release from human skin mast cells and basophils’, International Archives of Allergy and Immunology, 108(3), pp. 224-230

To top